Deeva I, Mariani S, De Luca C, et al.. Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease. Cytokine. 2010 Feb;49(2):163-70.
Date Published: February 2010
Keywords:
View Abstract
Takahashi H, Takahashi I, Honma M, et al.. Prevalence of metabolic syndrome in Japanese psoriasis patients. J Dermatol Sci. 2010 Feb;57(2):143-4.
Date Published: February 2010
Keywords:
View Abstract
Van den Bosch F, Manger B, Goupille P, et al.. Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann Rheum Dis. 2010 Feb;69(2):394-9.
Date Published: February 2010
Keywords:
View Abstract
Balci A, Balci DD, Yonden Z, et al.. Increased amount of visceral fat in patients with psoriasis contributes to metabolic syndrome. Dermatology. 2010;220(1):32-7.
Date Published: January 2010
Keywords:
View Abstract
Gerdes S, Zahl VA, Weichenthal M, et al.. Smoking and alcohol intake in severely affected patients with psoriasis in Germany. Dermatology. 2010;220(1):38-43.
Date Published: January 2010
Keywords:
View Abstract
Mease PJ, Signorovitch J, Yu AP, et al.. Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials. Dermatology. 2010;220(1):1-7.
Date Published: January 2010
Keywords:
View Abstract
Menter A, Korman NJ, Elmets CA, et al.. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol. 2010 Jan;62(1):114-35.
Date Published: January 2010
Keywords:
View Abstract
Puig L, Barco D, Alomar A. Treatment of psoriasis with anti-TNF drugs during pregnancy: case report and review of the literature. Dermatology. 2010;220(1):71-6.
Date Published: January 2010
Keywords:
View Abstract
Schäfer I, Hacker J, Rustenbach SJ, et al.. Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment. Eur J Dermatol. 2010 Jan-Feb;20(1):62-7.
Date Published: January 2010
Keywords:
View Abstract
Steinman L. Mixed results with modulation of TH-17 cells in human autoimmune diseases. Nat Immunol. 2010 Jan;11(1):41-4.
Date Published: January 2010
Keywords:
View Abstract
Zhou H, Hu C, Zhu Y, et al.. Population-based exposure-efficacy modeling of ustekinumab in patients with moderate to severe plaque psoriasis. J Clin Pharmacol. 2010 Mar;50(3):257-67.
Date Published: January 2010
Keywords:
View Abstract
No authors listed.. Psoriasis. Inflammatory disorder may be more than skin deep. Mayo Clin Womens Healthsource. 2009 Dec;13(12):4-5.
Date Published: December 2009
Keywords:
View Abstract
No authors listed.. Childhood psoriasis: often favorable outcome. Prescrire Int. 2009 Dec;18(104):275.
Date Published: December 2009
Keywords:
View Abstract
Bergman R, Ramon M, Wildbaum G, et al.. Psoriasis patients generate increased serum levels of autoantibodies to tumor necrosis factor-alpha and interferon-alpha. J Dermatol Sci. 2009 Dec;56(3):163-7.
Date Published: December 2009
Keywords:
View Abstract
Birkenfeld S, Dreiher J, Weitzman D, et al.. Coeliac disease associated with psoriasis. Br J Dermatol. 2009 Dec;161(6):1331-4.
Date Published: December 2009
Keywords:
View Abstract
Burmester GR, Mease P, Dijkmans BA, et al.. Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Ann Rheum Dis. 2009 Dec;68(12):1863-9.
Date Published: December 2009
Keywords:
View Abstract
Coimbra S, Oliveira H, Reis F, et al.. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol. 2009 Dec 11. [Epub ahead of print]
Date Published: December 2009
Keywords:
View Abstract
Conaghan PG, Coates LC. Improving recognition of psoriatic arthritis. Practitioner. 2009 Dec;253(1724):15-8, 2-3.
Date Published: December 2009
Keywords:
View Abstract
Dawe RS. Comparing narrowband ultraviolet B treatment regimens for psoriasis. Br J Dermatol. 2009 Dec;161(6):1215-6.
Date Published: December 2009
Keywords:
View Abstract
Duffin KC, Freeny IC, Schrodi SJ, et al.. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol. 2009 Dec;129(12):2777-83.
Date Published: December 2009
Keywords:
View Abstract
Elliott M, Benson J, Blank M, et al.. Ustekinumab: lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases. Ann N Y Acad Sci. 2009 Dec;1182():97-110.
Date Published: December 2009
Keywords:
View Abstract
Eyerich S, Eyerich K, Pennino D, et al.. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest. 2009 Dec;119(12):3573-85.
Date Published: December 2009
Keywords:
View Abstract
Foley P, Freeman M, Gebauer K, et al.. Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis: results from an Australian expanded access program. Int J Dermatol. 2009 Dec;48(12):1376-84.
Date Published: December 2009
Keywords:
View Abstract
Frankel AJ, Van Voorhees AS, Hsu S, et al.. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009 Dec;61(6):1044-55.
Date Published: December 2009
Keywords:
View Abstract
Frankel AJ, Van Voorhees AS, Hsu S, et al.. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009 Dec;61(6):1044-55.
Date Published: December 2009
Keywords:
View Abstract
Ghate JV, Alspaugh CD. Adalimumab in the management of palmoplantar psoriasis. J Drugs Dermatol. 2009 Dec;8(12):1136-9.
Date Published: December 2009
Keywords:
View Abstract
Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med. 2009 Dec;122(12):1150.e1-9.
Date Published: December 2009
Keywords:
View Abstract
Guibal F, Iversen L, Puig L, et al.. Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid. Curr Med Res Opin. 2009 Dec;25(12):2835-43.
Date Published: December 2009
Keywords:
View Abstract
Kagami S, Rizzo HL, Lee JJ, et al.. Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis. J Invest Dermatol. 2009 Dec 24. [Epub ahead of print]
Date Published: December 2009
Keywords:
View Abstract
Kleinpenning MM, Smits T, Boezeman J, et al.. Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimens. Br J Dermatol. 2009 Dec;161(6):1351-6.
Date Published: December 2009
Keywords:
View Abstract
Kunz M. Current treatment of psoriasis with biologics. Curr Drug Discov Technol. 2009 Dec;6(4):231-40.
Date Published: December 2009
Keywords:
View Abstract
Li Y, Begovich AB. Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis. Semin Immunol. 2009 Dec;21(6):318-27.
Date Published: December 2009
Keywords:
View Abstract
Mahajan R, Kaur I, Kanwar A. Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis - a randomized single-blinded placebo-controlled study. J Eur Acad Dermatol Venereol. 2009 Dec 15. [Epub ahead of print]
Date Published: December 2009
Keywords:
View Abstract
Mehta NN, Azfar RS, Shin DB, et al.. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2009 Dec 27. [Epub ahead of print]
Date Published: December 2009
Keywords:
View Abstract
Naldi L, Mercuri SR. Smoking and psoriasis: from epidemiology to pathomechanisms. J Invest Dermatol. 2009 Dec;129(12):2741-3.
Date Published: December 2009
Keywords:
View Abstract
Salgo R, Thaçi D. Treatment of moderate-to-severe plaque psoriasis. G Ital Dermatol Venereol. 2009 Dec;144(6):701-11.
Date Published: December 2009
Keywords:
View Abstract
Schafer P, Parton A, Gandhi A, et al.. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis. Br J Pharmacol. 2009 Dec 24. [Epub ahead of print]
Date Published: December 2009
Keywords:
View Abstract
Schmitt J, Ford DE. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol. 2009 Dec 10. [Epub ahead of print]
Date Published: December 2009
Keywords:
View Abstract
Seidler EM, Kimball AB. Socioeconomic disability in psoriasis. Br J Dermatol. 2009 Dec;161(6):1410-2.
Date Published: December 2009
Keywords:
View Abstract
Seidler EM, Kimball AB. Socioeconomic disability in psoriasis. Br J Dermatol. 2009 Dec;161(6):1410-2.
Date Published: December 2009
Keywords:
View Abstract
Spuls PI, Lecluse LL, Poulsen ML, et al.. How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review. J Invest Dermatol. 2009 Dec 31. [Epub ahead of print]
Date Published: December 2009
Keywords:
View Abstract
Stone MA, White LM, Gladman DD, et al.. Significance of clinical evaluation of the metacarpophalangeal joint in relation to synovial/bone pathology in rheumatoid and psoriatic arthritis detected by magnetic resonance imaging. J Rheumatol. 2009 Dec;36(12):2751-7.
Date Published: December 2009
Keywords:
View Abstract
Takaoka K, Shirai Y, Saito N. Inflammatory cytokine tumor necrosis factor-alpha enhances nerve growth factor production in human keratinocytes, HaCaT cells. J Pharmacol Sci. 2009 Dec;111(4):381-91.
Date Published: December 2009
Keywords:
View Abstract
Tansey MG, Szymkowski DE. The TNF superfamily in 2009: new pathways, new indications, and new drugs. Drug Discov Today. 2009 Dec;14(23-24):1082-8.
Date Published: December 2009
Keywords:
View Abstract
Tansey MG, Szymkowski DE. The TNF superfamily in 2009: new pathways, new indications, and new drugs. Drug Discov Today. 2009 Dec;14(23-24):1082-8.
Date Published: December 2009
Keywords:
View Abstract
Tiberio R, Bozzo C, Pertusi G, et al.. Calcipotriol induces apoptosis in psoriatic keratinocytes. Clin Exp Dermatol. 2009 Dec;34(8):e972-4.
Date Published: December 2009
Keywords:
View Abstract
Tollefson MM, Crowson CS, McEvoy MT, et al.. Incidence of psoriasis in children: A population-based study. J Am Acad Dermatol. 2009 Dec 3. [Epub ahead of print]
Date Published: December 2009
Keywords:
View Abstract
van de Kerkhof PC. The relevance of biologics for the treatment of patients with psoriasis. Br J Dermatol. 2009 Dec;161(6):1213-4.
Date Published: December 2009
Keywords:
View Abstract
Wolk K, Witte E, Warszawska K, et al.. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. Eur J Immunol. 2009 Dec;39(12):3570-81.
Date Published: December 2009
Keywords:
View Abstract
Zhang L, Yang XQ, Cheng J, et al.. Clin Immunol Fla.)". 2009 Dec 11. [Epub ahead of print]
Date Published: December 2009
Keywords:
View Abstract
Anandarajah AP, Ritchlin CT. The diagnosis and treatment of early psoriatic arthritis. Nat Rev Rheumatol. 2009 Nov;5(11):634-41.
Date Published: November 2009
Keywords:
View Abstract
Anandarajah AP, Ritchlin CT. The diagnosis and treatment of early psoriatic arthritis. Nat Rev Rheumatol. 2009 Nov;5(11):634-41.
Date Published: November 2009
Keywords:
View Abstract
Au WY, Yeung CK. Acute promyelocytic leukemia in patients with severe psoriasis vulgaris. Leuk Res. 2009 Nov;33(11):e189-90.
Date Published: November 2009
Keywords:
View Abstract
Augustin M, Glaeske G, Radtke MA, et al.. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2009 Nov 18. [Epub ahead of print]
Date Published: November 2009
Keywords:
View Abstract
Brauchli YB, Jick SS, Miret M, et al.. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol. 2009 Nov;129(11):2604-12.
Date Published: November 2009
Keywords:
View Abstract
Caruso R, Costanzo A, Monteleone G. Cell Cycle Tex.)". 2009 Nov 15;8(22):3629-30.
Date Published: November 2009
Keywords:
View Abstract
Chua RA, Arbiser JL. The role of angiogenesis in the pathogenesis of psoriasis. Autoimmunity. 2009 Nov;42(7):574-9.
Date Published: November 2009
Keywords:
View Abstract
Claréus BW, Houwing R, Sindrup JH, et al.. The DESIRE study--psoriasis patients’ satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice. Eur J Dermatol. 2009 Nov-Dec;19(6):581-5.
Date Published: November 2009
Keywords:
View Abstract
Claréus BW, Houwing R, Sindrup JH, et al.. The DESIRE study--psoriasis patients’ satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice. Eur J Dermatol. 2009 Nov-Dec;19(6):581-5.
Date Published: November 2009
Keywords:
View Abstract
de Jager ME, de Jong EM, M van de Kerkhof PC, et al.. Efficacy and safety of treatments for childhood psoriasis: A systematic literature review. J Am Acad Dermatol. 2009 Nov 7. [Epub ahead of print]
Date Published: November 2009
Keywords:
View Abstract
Dommasch ED, Shin DB, Troxel AB, et al.. Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis. Br J Dermatol. 2009 Nov 10. [Epub ahead of print]
Date Published: November 2009
Keywords:
View Abstract
El-Mongy S, Fathy H, Abdelaziz A, et al.. Subclinical atherosclerosis in patients with chronic psoriasis: a potential association. J Eur Acad Dermatol Venereol. 2009 Nov 2. [Epub ahead of print]
Date Published: November 2009
Keywords:
View Abstract
Gardinal I, Ammoury A, Paul C. Moderate to severe psoriasis: from topical to biological treatment. J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1324-6.
Date Published: November 2009
Keywords:
View Abstract
Gowda S, Goldblum OM, McCall WV, et al.. Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol. 2009 Nov 25. [Epub ahead of print]
Date Published: November 2009
Keywords:
View Abstract
Hazarika D. Indian J Dermatol Venereol Leprol venereology and leprology". 2009 Nov-Dec;75(6):638.
Date Published: November 2009
Keywords:
View Abstract
Hüffmeier U, Lascorz J, Becker T, et al.. Characterisation of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1. J Med Genet. 2009 Nov;46(11):736-44.
Date Published: November 2009
Keywords:
View Abstract
Karason A, Love TJ, Gudbjornsson B. Rheumatology (Oxford) England)". 2009 Nov;48(11):1424-8.
Date Published: November 2009
Keywords:
View Abstract
Kimball AB, Wu Y. Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis. Int J Dermatol. 2009 Nov;48(11):1147-56.
Date Published: November 2009
Keywords:
View Abstract
Kleyn CE, McKie S, Ross AR, et al.. Diminished neural and cognitive responses to facial expressions of disgust in patients with psoriasis: a functional magnetic resonance imaging study. J Invest Dermatol. 2009 Nov;129(11):2613-9.
Date Published: November 2009
Keywords:
View Abstract
Lebwohl M, Papp K, Han C, et al.. Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial. Br J Dermatol. 2009 Nov 9. [Epub ahead of print]
Date Published: November 2009
Keywords:
View Abstract
Lee CS, Li K. A review of acitretin for the treatment of psoriasis. Expert Opin Drug Saf. 2009 Nov;8(6):769-79.
Date Published: November 2009
Keywords:
View Abstract
Levine D, Gottlieb A. Evaluation and management of psoriasis: an internist’s guide. Med Clin North Am. 2009 Nov;93(6):1291-303.
Date Published: November 2009
Keywords:
View Abstract
Mahler R, Jackson C, Ijacu H. The burden of psoriasis and barriers to satisfactory care: results from a Canadian patient survey. J Cutan Med Surg. 2009 Nov-Dec;13(6):283-93.
Date Published: November 2009
Keywords:
View Abstract
Manicassamy S. Sotrastaurin, a protein kinase C inhibitor for the prevention of transplant rejection and treatment of psoriasis. Curr Opin Investig Drugs. 2009 Nov;10(11):1225-35.
Date Published: November 2009
Keywords:
View Abstract
Melwani PM, Peñate Y, Guillermo N, et al.. Leflunomide in the treatment of palmoplantar pustulosis. Arch Dermatol. 2009 Nov;145(11):1224-6.
Date Published: November 2009
Keywords:
View Abstract
Mikhael D, Babcock K, DesGroseilliers JP. Cost comparison of psoriasis treatments. J Cutan Med Surg. 2009 Nov-Dec;13(6):303-7.
Date Published: November 2009
Keywords:
View Abstract
Nazarian R, Weinberg JM. AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis. Curr Opin Investig Drugs. 2009 Nov;10(11):1236-42.
Date Published: November 2009
Keywords:
View Abstract
Niwa Y, Hasegawa T, Ko S, et al.. Efficacy of 308-nm excimer light for Japanese patients with psoriasis. J Dermatol. 2009 Nov;36(11):579-82.
Date Published: November 2009
Keywords:
View Abstract
Ortonne JP, Taïeb A, Ormerod AD, et al.. Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept. Br J Dermatol. 2009 Nov;161(5):1190-5.
Date Published: November 2009
Keywords:
View Abstract
Oudot T, Lesueur F, Guedj M, et al.. An association study of 22 candidate genes in psoriasis families reveals shared genetic factors with other autoimmune and skin disorders. J Invest Dermatol. 2009 Nov;129(11):2637-45.
Date Published: November 2009
Keywords:
View Abstract
Paul CF, Gourraud PA. Cancer risk evaluation in psoriasis: in search of the Holy Grail? J Invest Dermatol. 2009 Nov;129(11):2547-9.
Date Published: November 2009
Keywords:
View Abstract
Pugashetti R, Lim HW, Koo J. Broadband UVB revisited: Is the narrowband UVB fad limiting our therapeutic options? J Dermatolog Treat. 2009 Nov 7. [Epub ahead of print]
Date Published: November 2009
Keywords:
View Abstract
Richetta AG, Maiani E, Carlomagno V, et al.. Treatment of erythrodermic psoriasis in HCV+ patient with adalimumab. Dermatol Ther. 2009 Nov;22 Suppl 1():S16-8.
Date Published: November 2009
Keywords:
View Abstract
Rosmarin DM, Lebwohl M, Elewski BE, et al.. Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol. 2009 Nov 23. [Epub ahead of print]
Date Published: November 2009
Keywords:
View Abstract
Shibata S, Tada Y, Kanda N, et al.. Possible Roles of IL-27 in the Pathogenesis of Psoriasis. J Invest Dermatol. 2009 Nov 19. [Epub ahead of print]
Date Published: November 2009
Keywords:
View Abstract
Sivanesan SP, Gattu S, Hong J, et al.. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks. J Am Acad Dermatol. 2009 Nov;61(5):793-8.
Date Published: November 2009
Keywords:
View Abstract
Sivanesan SP, Gattu S, Hong J, et al.. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks. J Am Acad Dermatol. 2009 Nov;61(5):793-8.
Date Published: November 2009
Keywords:
View Abstract
Smith CH, Anstey AV, Barker JN, et al.. British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009. Br J Dermatol. 2009 Nov;161(5):987-1019.
Date Published: November 2009
Keywords:
View Abstract
Smith D. A new view on psoriasis research efforts. J Eur Acad Dermatol Venereol. 2009 Nov 30. [Epub ahead of print]
Date Published: November 2009
Keywords:
View Abstract
Smith N, Weymann A, Tausk FA, et al.. Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature. J Am Acad Dermatol. 2009 Nov;61(5):841-56.
Date Published: November 2009
Keywords:
View Abstract
Wasel N, Poulin Y, Andrew R, et al.. A Canadian self-administered online survey to evaluate the impact of moderate-to-severe psoriasis among patients. J Cutan Med Surg. 2009 Nov-Dec;13(6):294-302.
Date Published: November 2009
Keywords:
View Abstract
Xiao J, Chen LH, Tu YT, et al.. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1311-5.
Date Published: November 2009
Keywords:
View Abstract
Yamamoto T. Extra-palmoplantar lesions associated with palmoplantar pustulosis. J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1227-32.
Date Published: November 2009
Keywords:
View Abstract
Zaba LC, Suárez-Fariñas M, Fuentes-Duculan J, et al.. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol. 2009 Nov;124(5):1022-10.e1-395.
Date Published: November 2009
Keywords:
View Abstract
No authors listed.. Ustekinumab: new drug. Suspicion of carcinogenicity: too great a risk for psoriasis patients. Prescrire Int. 2009 Oct;18(103):202-4.
Date Published: October 2009
Keywords:
View Abstract
Adi?en E, Gürer MA. Therapeutic options for palmoplantar pustulosis. Clin Exp Dermatol. 2009 Oct 23. [Epub ahead of print]
Date Published: October 2009
Keywords:
View Abstract
Bagel J. Topical therapies for the treatment of plaque psoriasis. Cutis. 2009 Oct;84(4 Suppl):3-13.
Date Published: October 2009
Keywords:
View Abstract
Balkrishnan R, Bhosle MJ, Fleischer AB, et al.. Prior authorization for topical psoriasis treatments: Is it cost-beneficial for managed care? J Dermatolog Treat. 2009 Oct 13. [Epub ahead of print]
Date Published: October 2009
Keywords:
View Abstract
Ben Salem C, Hmouda H, Bouraoui K. Psoriasis. N Engl J Med. 2009 Oct 22;361(17):1710; author reply 1710.
Date Published: October 2009
Keywords:
View Abstract
Bicer A, Acikel S, Kilic H, et al.. Impaired aortic elasticity in patients with psoriasis. Acta Cardiol. 2009 Oct;64(5):597-602.
Date Published: October 2009
Keywords:
View Abstract
Bovenschen H, Van de Kerkhof P. Treatment of scalp psoriasis with clobetasol-17 propionate 0.05% shampoo: a study on daily clinical practice. J Eur Acad Dermatol Venereol. 2009 Oct 21. [Epub ahead of print]
Date Published: October 2009
Keywords:
View Abstract
Caldarola G, De Simone C, Carbone A, et al.. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept. Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):961-6.
Date Published: October 2009
Keywords:
View Abstract
Christophers E, Barker J, Griffiths C, et al.. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol. 2009 Oct 23. [Epub ahead of print]
Date Published: October 2009
Keywords:
View Abstract
Dernis E, Lavie F, Salliot C, et al.. spine : revue du rhumatisme" bone. 2009 Oct;76(5):524-31.
Date Published: October 2009
Keywords:
View Abstract
Dominguez PL, Assarpour A, Kuo H, et al.. Development and pilot-testing of a psoriasis screening tool. Br J Dermatol. 2009 Oct;161(4):778-84.
Date Published: October 2009
Keywords:
View Abstract
Elder JT, Bruce AT, Gudjonsson JE, et al.. Molecular Dissection of Psoriasis: Integrating Genetics and Biology. J Invest Dermatol. 2009 Oct 8. [Epub ahead of print]
Date Published: October 2009
Keywords:
View Abstract
Feldman SR, Koo JY, Johnson LA, et al.. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis. Cutis. 2009 Oct;84(4 Suppl):25-32.
Date Published: October 2009
Keywords:
View Abstract
Fernández-Guarino M, Jaén P. Laser in psoriasis. G Ital Dermatol Venereol. 2009 Oct;144(5):573-81.
Date Published: October 2009
Keywords:
View Abstract
Fitch EL, Rizzo HL, Kurtz SE, et al.. Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway. J Invest Dermatol. 2009 Oct;129(10):2443-50.
Date Published: October 2009
Keywords:
View Abstract
Gelfand JM, Dommasch ED, Shin DB, et al.. The risk of stroke in patients with psoriasis. J Invest Dermatol. 2009 Oct;129(10):2411-8.
Date Published: October 2009
Keywords:
View Abstract
Gisondi P, Targher G, Zoppini G, et al.. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009 Oct;51(4):758-64.
Date Published: October 2009
Keywords:
View Abstract
Husted JA, Tom BD, Schentag CT, et al.. Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis. 2009 Oct;68(10):1553-8.
Date Published: October 2009
Keywords:
View Abstract
Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum. 2009 Oct 15;61(10):1373-8.
Date Published: October 2009
Keywords:
View Abstract
Kumar U, Kaur I, Dogra S, et al.. Topical tazarotene vs. coal tar in stable plaque psoriasis. Clin Exp Dermatol. 2009 Oct 23. [Epub ahead of print]
Date Published: October 2009
Keywords:
View Abstract
Laffitte E, Janssens JP, Roux-Lombard P, et al.. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test. Br J Dermatol. 2009 Oct;161(4):797-800.
Date Published: October 2009
Keywords:
View Abstract
Langenbruch A, Schäfer I, Franzke N, et al.. Internet-supported gathering of treatment data and patient benefits in psoriasis. J Eur Acad Dermatol Venereol. 2009 Oct 21. [Epub ahead of print]
Date Published: October 2009
Keywords:
View Abstract
Lavie F, Salliot C, Dernis E, et al.. spine : revue du rhumatisme" bone. 2009 Oct;76(5):540-6.
Date Published: October 2009
Keywords:
View Abstract
Lecluse LL, de Groot M, Bos JD, et al.. Experience with biologics for psoriasis in daily practice: switching is worth a try. Br J Dermatol. 2009 Oct;161(4):948-51.
Date Published: October 2009
Keywords:
View Abstract
López Castillo V, Molina Gallardo I, Martà Fajardo N, et al.. Severe nail psoriasis with a rapid response to acitretin. Clin Exp Dermatol. 2009 Oct;34(7):e332-3.
Date Published: October 2009
Keywords:
View Abstract
Marchesoni A, Altomare G, Matucci-Cerinic M, et al.. An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease. J Eur Acad Dermatol Venereol. 2009 Oct 23. [Epub ahead of print]
Date Published: October 2009
Keywords:
View Abstract
Melnikova I. Psoriasis market. Nat Rev Drug Discov. 2009 Oct;8(10):767-8.
Date Published: October 2009
Keywords:
View Abstract
Menter A. The status of biologic therapies in the treatment of moderate to severe psoriasis. Cutis. 2009 Oct;84(4 Suppl):14-24.
Date Published: October 2009
Keywords:
View Abstract
Miele L, Vallone S, Cefalo C, et al.. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009 Oct;51(4):778-86.
Date Published: October 2009
Keywords:
View Abstract
Miot HA, Miot LD, Lopes PS, et al.. Association between palmoplantar pustulosis and cigarette smoking in Brazil: a case-control study. J Eur Acad Dermatol Venereol. 2009 Oct;23(10):1173-7.
Date Published: October 2009
Keywords:
View Abstract
Pathirana D, Ormerod AD, Saiag P, et al.. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009 Oct;23 Suppl 2():1-70.
Date Published: October 2009
Keywords:
View Abstract
Pérez-Pérez L, Allegue F, Caeiro JL, et al.. Severe psoriasis, morbid obesity and bariatric surgery. Clin Exp Dermatol. 2009 Oct;34(7):e421-2.
Date Published: October 2009
Keywords:
View Abstract
Peternel S, Kastelan M. Immunopathogenesis of psoriasis: focus on natural killer T cells. J Eur Acad Dermatol Venereol. 2009 Oct;23(10):1123-7.
Date Published: October 2009
Keywords:
View Abstract
Prignano F, Pescitelli L, Ricceri F, et al.. Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. J Eur Acad Dermatol Venereol. 2009 Oct 23. [Epub ahead of print]
Date Published: October 2009
Keywords:
View Abstract
Rigopoulos D, Gregoriou S, Lazaridou E, et al.. Treatment of nail psoriasis with adalimumab: an open label unblinded study. J Eur Acad Dermatol Venereol. 2009 Oct 6. [Epub ahead of print]
Date Published: October 2009
Keywords:
View Abstract
Ryan C, Kirby B, Collins P, et al.. Adalimumab treatment for severe recalcitrant chronic plaque psoriasis. Clin Exp Dermatol. 2009 Oct;34(7):784-8.
Date Published: October 2009
Keywords:
View Abstract
Salliot C, Dernis E, Lavie F, et al.. spine : revue du rhumatisme" bone. 2009 Oct;76(5):532-9.
Date Published: October 2009
Keywords:
View Abstract
Saraceno R, Gramiccia T, Frascione P, et al.. Calcipotriene/betamethasone in the treatment of psoriasis: a review article. Expert Opin Pharmacother. 2009 Oct;10(14):2357-65.
Date Published: October 2009
Keywords:
View Abstract
Seckin D, Usta I, Yazici Z, et al.. Photodermatol Photoimmunol Photomed photoimmunology & photomedicine". 2009 Oct;25(5):237-41.
Date Published: October 2009
Keywords:
View Abstract
Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL, et al.. Psoriasis--as an autoimmune disease caused by molecular mimicry. Trends Immunol. 2009 Oct;30(10):494-501.
Date Published: October 2009
Keywords:
View Abstract
Volpe E, Touzot M, Servant N, et al.. Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood. 2009 Oct 22;114(17):3610-4.
Date Published: October 2009
Keywords:
View Abstract
Wakkee M, Herings RM, Nijsten T. Psoriasis May Not be an Independent Risk Factor for Acute Ischemic Heart Disease Hospitalizations: Results of a Large Population-Based Dutch Cohort. J Invest Dermatol. 2009 Oct 8. [Epub ahead of print]
Date Published: October 2009
Keywords:
View Abstract
Zhou C, Yu X, Cai D, et al.. Role of corticotropin-releasing hormone and receptor in the pathogenesis of psoriasis. Med Hypotheses. 2009 Oct;73(4):513-5.
Date Published: October 2009
Keywords:
View Abstract
Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med. 2009 Oct 1;47(7):891-905.
Date Published: October 2009
Keywords:
View Abstract
No authors listed.. New views on nail anatomy and psoriasis. Introduction. J Eur Acad Dermatol Venereol. 2009 Sep;23 Suppl 1():1.
Date Published: September 2009
Keywords:
View Abstract
No authors listed.. Psoriasis may tie in with coronary artery disease. Mayo Clin Health Lett. 2009 Sep;27(9):4.
Date Published: September 2009
Keywords:
View Abstract
No authors listed.. Calcitriol (Vectical) for mild to moderate plaque psoriasis. Med Lett Drugs Ther. 2009 Sep 7;51(1320):70-1.
Date Published: September 2009
Keywords:
View Abstract
No authors listed.. New guidelines for managing psoriasis with systemic medications. Dermatol Nurs. 2009 Sep-Oct;21(5):301-3.
Date Published: September 2009
Keywords:
View Abstract
Alwawi EA, Krulig E, Gordon KB. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know? Dermatol Ther. 2009 Sep-Oct;22(5):431-40.
Date Published: September 2009
Keywords:
View Abstract
Amital H, Arnson Y, Chodick G, et al.. Rheumatology (Oxford) England)". 2009 Sep;48(9):1107-10.
Date Published: September 2009
Keywords:
View Abstract
Biljan D, Laufer D, Filakovi? P, et al.. Psoriasis, mental disorders and stress. Coll Antropol. 2009 Sep;33(3):889-92.
Date Published: September 2009
Keywords:
View Abstract
Bissonnette R, Ho V, Langley RG. Safety of conventional systemic agents and biologic agents in the treatment of psoriasis. J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2():S67-76.
Date Published: September 2009
Keywords:
View Abstract
Boy MG, Wang C, Wilkinson BE, et al.. Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis. J Invest Dermatol. 2009 Sep;129(9):2299-302.
Date Published: September 2009
Keywords:
View Abstract
Butbul YA, Tyrrell PN, Schneider R, et al.. Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they? J Rheumatol. 2009 Sep;36(9):2033-41.
Date Published: September 2009
Keywords:
View Abstract
Caruso R, Botti E, Sarra M, et al.. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med. 2009 Sep;15(9):1013-5.
Date Published: September 2009
Keywords:
View Abstract
Chandran V, Gottlieb A, Cook RJ, et al.. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum. 2009 Sep 15;61(9):1235-42.
Date Published: September 2009
Keywords:
View Abstract
Dominguez PL, Husni ME, Holt EW, et al.. Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res. 2009 Sep;301(8):573-9.
Date Published: September 2009
Keywords:
View Abstract
Dommasch E, Gelfand JM. Is there truly a risk of lymphoma from biologic therapies? Dermatol Ther. 2009 Sep-Oct;22(5):418-30.
Date Published: September 2009
Keywords:
View Abstract
Ejaz A, Iftikhar A, Iftikhar N. Patterns of psoriatic arthritis. J Coll Physicians Surg Pak. 2009 Sep;19(9):553-6.
Date Published: September 2009
Keywords:
View Abstract
Evers AW, Kleinpenning MM, Smits T, et al.. Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapy. Br J Dermatol. 2009 Sep;161(3):542-6.
Date Published: September 2009
Keywords:
View Abstract
Girolomoni G, Gisondi P. Psoriasis and systemic inflammation: underdiagnosed enthesopathy. J Eur Acad Dermatol Venereol. 2009 Sep;23 Suppl 1():3-8.
Date Published: September 2009
Keywords:
View Abstract
Goodman WA, Levine AD, Massari JV, et al.. J Immunol Md. : 1950)". 2009 Sep 1;183(5):3170-6.
Date Published: September 2009
Keywords:
View Abstract
Gottlieb AB, Kardos M, Yee M. Current biologic treatments for psoriasis. Dermatol Nurs. 2009 Sep-Oct;21(5):259-66, 272; quiz 267.
Date Published: September 2009
Keywords:
View Abstract
GREINER RA, Braathen LR. Cost-effectiveness of biologics for moderate-to-severe psoriasis from the perspective of the Swiss healthcare system. Eur J Dermatol. 2009 Sep-Oct;19(5):494-9.
Date Published: September 2009
Keywords:
View Abstract
Guenther L, Gulliver W. Psoriasis comorbidities. J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2():S77-87.
Date Published: September 2009
Keywords:
View Abstract
Gupta AK, Cooper EA. Psoriatic nail disease: quality of life and treatment. J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2():S102-6.
Date Published: September 2009
Keywords:
View Abstract
Harper EG, Guo C, Rizzo H, et al.. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol. 2009 Sep;129(9):2175-83.
Date Published: September 2009
Keywords:
View Abstract
Kirschner N, Poetzl C, von den Driesch P, et al.. Alteration of tight junction proteins is an early event in psoriasis: putative involvement of proinflammatory cytokines. Am J Pathol. 2009 Sep;175(3):1095-106.
Date Published: September 2009
Keywords:
View Abstract
Kossakowska MM, Cie?ci?ska C, Jaszewska J, et al.. Control of negative emotions and its implication for illness perception among psoriasis and vitiligo patients. J Eur Acad Dermatol Venereol. 2009 Sep 10. [Epub ahead of print]
Date Published: September 2009
Keywords:
View Abstract
Lynde CW, Poulin Y, Guenther L, et al.. The burden of psoriasis in Canada: insights from the pSoriasis Knowledge IN Canada (SKIN) survey. J Cutan Med Surg. 2009 Sep-Oct;13(5):235-52.
Date Published: September 2009
Keywords:
View Abstract
Makredes M, Robinson D, Bala M, et al.. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J Am Acad Dermatol. 2009 Sep;61(3):405-10.
Date Published: September 2009
Keywords:
View Abstract
McGonagle D. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease. J Eur Acad Dermatol Venereol. 2009 Sep;23 Suppl 1():9-13.
Date Published: September 2009
Keywords:
View Abstract
Menter A, Korman NJ, Elmets CA, et al.. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009 Sep;61(3):451-85.
Date Published: September 2009
Keywords:
View Abstract
Naldi L, Svensson A, Zenoni D, et al.. Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006. Br J Dermatol. 2009 Sep 24. [Epub ahead of print]
Date Published: September 2009
Keywords:
View Abstract
Nast A, Erdmann R, Hofelich V, et al.. Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines. Arch Dermatol Res. 2009 Sep;301(8):553-9.
Date Published: September 2009
Keywords:
View Abstract
O’Rielly DD, Rahman P. Evaluation for psoriatic arthritis in dermatology clinics. J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2():S88-92.
Date Published: September 2009
Keywords:
View Abstract
Papp K, Okun M, Vender R. Adalimumab in the treatment of psoriasis: pooled efficacy and safety results from three pivotal studies. J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2():S58-66.
Date Published: September 2009
Keywords:
View Abstract
Pappas DA, Bathon JM, Hanicq D, et al.. Golimumab. Nat Rev Drug Discov. 2009 Sep;8(9):695-6.
Date Published: September 2009
Keywords:
View Abstract
Poulin Y, Bourcier M. Practical aspects of prescribing a biologic. J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2():S93-S101.
Date Published: September 2009
Keywords:
View Abstract
Poulin Y, Langley RG, Teixeira HD, et al.. Biologics in the treatment of psoriasis: clinical and economic overview. J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2():S49-57.
Date Published: September 2009
Keywords:
View Abstract
Prignano F, Ricceri F, Pescitelli L, et al.. Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. Curr Med Res Opin. 2009 Sep;25(9):2311-6.
Date Published: September 2009
Keywords:
View Abstract
Reich K. Approach to managing patients with nail psoriasis. J Eur Acad Dermatol Venereol. 2009 Sep;23 Suppl 1():15-21.
Date Published: September 2009
Keywords:
View Abstract
Ritchlin CT, Kavanaugh A, Gladman DD, et al.. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis. 2009 Sep;68(9):1387-94.
Date Published: September 2009
Keywords:
View Abstract
Scanlon JV, Exter BP, Steinberg M, et al.. Ustekinumab: treatment of adult moderate-to-severe chronic plaque psoriasis. Ann Pharmacother. 2009 Sep;43(9):1456-65.
Date Published: September 2009
Keywords:
View Abstract
Tobin AM, Kirby B. Psoriasis: an opportunity to identify cardiovascular risk. Br J Dermatol. 2009 Sep;161(3):719.
Date Published: September 2009
Keywords:
View Abstract
Turner D, Picot J, Cooper K, et al.. Health Technol Assess England)". 2009 Sep;13 Suppl 2():49-54.
Date Published: September 2009
Keywords:
View Abstract
Weger W, Hofer A, Wolf P, et al.. Common polymorphisms in the interleukin-22 gene are not associated with chronic plaque psoriasis. Exp Dermatol. 2009 Sep;18(9):796-8.
Date Published: September 2009
Keywords:
View Abstract
Xu Z, Vu T, Lee H, et al.. Population pharmacokinetics of golimumab, an anti-tumor necrosis factor-alpha human monoclonal antibody, in patients with psoriatic arthritis. J Clin Pharmacol. 2009 Sep;49(9):1056-70.
Date Published: September 2009
Keywords:
View Abstract
Zamberk P, Velázquez D, Campos M, et al.. Paediatric psoriasis - narrowband UVB treatment. J Eur Acad Dermatol Venereol. 2009 Sep 14. [Epub ahead of print]
Date Published: September 2009
Keywords:
View Abstract
Altomare GF, Altomare A, Pigatto PD. Traditional systemic treatment of psoriasis. J Rheumatol Suppl. 2009 Aug;83():46-8.
Date Published: August 2009
Keywords:
View Abstract
Atzeni F, Sarzi-Puttini P, Vena GA. Resistant cases of psoriatic arthritis: how to manage them. J Rheumatol Suppl. 2009 Aug;83():73-5.
Date Published: August 2009
Keywords:
View Abstract
Ayala F, Ayala F. Clinical aspects and comorbidities of psoriasis. J Rheumatol Suppl. 2009 Aug;83():19-20.
Date Published: August 2009
Keywords:
View Abstract
Balato N, Di Costanzo L, Balato A. Differential diagnosis of psoriasis. J Rheumatol Suppl. 2009 Aug;83():24-5.
Date Published: August 2009
Keywords:
View Abstract
Brown BC, Warren RB, Grindlay DJ, et al. What's new in psoriasis? Analysis of the clinical significance of systematic reviews on psoriasis published in 2007 and 2008. Clin Exp Dermatol. 2009 Aug;34(6):664-7.
Date Published: August 2009
Keywords:
View Abstract
Carson KR, Focosi D, Major EO, et al. "Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab Lancet Oncol. 2009 Aug;10(8):816-24.
Date Published: August 2009
Keywords:
View Abstract
Caruso R, Botti E, Sarra M, et al. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med. 2009 Sep;15(9):1013-5.
Date Published: August 2009
Keywords:
View Abstract
Chandran V, Gottlieb A, Cook RJ, et al. "International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin Arthritis Rheum. 2009 Aug 31. [Epub ahead of print]
Date Published: August 2009
Keywords:
View Abstract
de Felice C, Ardigo M, Berardesca E. Biologic therapies for psoriasis. J Rheumatol Suppl. 2009 Aug;83():62-4.
Date Published: August 2009
Keywords:
View Abstract
Horn EJ, Chambers CD, Menter A, et al. Pregnancy outcomes in psoriasis: why do we know so little? J Am Acad Dermatol. 2009 Aug;61(2):e5-8.
Date Published: August 2009
Keywords:
View Abstract
Kircik L. "Efficacy and safety of topical calcitriol 3 microg/g ointment J Drugs Dermatol. 2009 Aug;8(8 Suppl):s9-16.
Date Published: August 2009
Keywords:
View Abstract
Kleyn CE, McKie S, Ross AR, et al. Diminished Neural and Cognitive Responses to Facial Expressions of Disgust in Patients with Psoriasis: A Functional Magnetic Resonance Imaging Study. J Invest Dermatol. 2009 Aug 27. [Epub ahead of print]
Date Published: August 2009
Keywords:
View Abstract
Korman BD, Tyler KL, Korman NJ. "Progressive multifocal leukoencephalopathy Arch Dermatol. 2009 Aug;145(8):937-42.
Date Published: August 2009
Keywords:
View Abstract
Lecluse LL, de Groot M, Bos JD, et al. Experience with biologics for psoriasis in daily practice: switching is worth a try. Br J Dermatol. 2009 Aug 7. [Epub ahead of print]
Date Published: August 2009
Keywords:
View Abstract
Lima XT, Abuabara K, Kimball AB, et al. Briakinumab. Expert Opin Biol Ther. 2009 Aug;9(8):1107-13.
Date Published: August 2009
Keywords:
View Abstract
Loffredo S, Ayala F, Marone G, et al. Immunopathogenesis of psoriasis and pharmacological perspectives. J Rheumatol Suppl. 2009 Aug;83():9-11.
Date Published: August 2009
Keywords:
View Abstract
Luger TA, Barker J, Lambert J, et al. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol. 2009 Aug;23(8):896-904.
Date Published: August 2009
Keywords:
View Abstract
Major EO. Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies. Annu Rev Med. 2009 Aug 31. [Epub ahead of print]
Date Published: August 2009
Keywords:
View Abstract
Marchesoni A, Ricci M, Moggio E, et al. Multidisciplinary focus on methotrexate in psoriatic disesase. J Rheumatol Suppl. 2009 Aug;83():56-8.
Date Published: August 2009
Keywords:
View Abstract
Moberg C, Alderling M, Meding B. Hand eczema and quality of life: a population-based study. Br J Dermatol. 2009 Aug;161(2):397-403.
Date Published: August 2009
Keywords:
View Abstract
Molloy ES, Calabrese LH. Therapy: Targeted but not trouble-free: efalizumab and PML. Nat Rev Rheumatol. 2009 Aug;5(8):418-9.
Date Published: August 2009
Keywords:
View Abstract
Monfrecola G, Baldo A. Retinoids and phototherapy for psoriasis. J Rheumatol Suppl. 2009 Aug;83():71-2.
Date Published: August 2009
Keywords:
View Abstract
Ortonne JP, Ganslandt C, Tan J, et al. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2009 Aug;23(8):919-26.
Date Published: August 2009
Keywords:
View Abstract
Pincelli C, Lotti R. What's new in laboratory research? J Rheumatol Suppl. 2009 Aug;83():17-8.
Date Published: August 2009
Keywords:
View Abstract
Ritchlin CT, Proulx S, Schwarz ES. Translational perspectives on psoriatic arthritis. J Rheumatol Suppl. 2009 Aug;83():30-4.
Date Published: August 2009
Keywords:
View Abstract
Rosenbach M, Hsu S, Korman NJ, et al. Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009 Aug 7. [Epub ahead of print]
Date Published: August 2009
Keywords:
View Abstract
Saber TP, Veale DJ. Psoriatic arthritis management update - biotherapeutic options. J Rheumatol Suppl. 2009 Aug;83():65-8.
Date Published: August 2009
Keywords:
View Abstract
Salvarani C, Boiardi L, Macchioni P, et al. Multidisciplinary focus on cyclosporin A. J Rheumatol Suppl. 2009 Aug;83():52-5.
Date Published: August 2009
Keywords:
View Abstract
Scanlon JV, Exter BP, Steinberg M, et al. Ustekinumab: treatment of adult moderate-to-severe chronic plaque psoriasis. Ann Pharmacother. 2009 Sep;43(9):1456-65.
Date Published: August 2009
Keywords:
View Abstract
Smith N, Weymann A, Tausk FA, et al. Complementary and alternative medicine for psoriasis: A qualitative review of the clinical trial literature. J Am Acad Dermatol. 2009 Aug 5. [Epub ahead of print]
Date Published: August 2009
Keywords:
View Abstract
Tanghetti EA. The role of topical vitamin D modulators in psoriasis therapy. J Drugs Dermatol. 2009 Aug;8(8 Suppl):s4-8.
Date Published: August 2009
Keywords:
View Abstract
Tobin AM, Higgins EM, Norris S, et al. Prevalence of psoriasis in patients with alcoholic liver disease. Clin Exp Dermatol. 2009 Aug;34(6):698-701.
Date Published: August 2009
Keywords:
View Abstract
van Kuijk AW, Gerlag DM, Vos K, et al. "A prospective Ann Rheum Dis. 2009 Aug;68(8):1303-9.
Date Published: August 2009
Keywords:
View Abstract
Alexandroff AB, Pauriah M, Camp RD, et al. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol. 2009 Jul;161(1):1-7.
Date Published: July 2009
Keywords:
View Abstract
Chong BF, Wong HK. Treatment of psoriasis with etanercept in a patient with a history of primary B-cell lymphoma. Clin Exp Dermatol. 2009 Jul;34(5):e11-3.
Date Published: July 2009
Keywords:
View Abstract
Beissert S, Pauser S, Sticherling M, et al. Dermatology Switzerland)". 2009 Jun 23. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Bissonnette R, Langley RG, Papp K, et al. Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab. Arch Dermatol Res. 2009 Jul;301(6):429-42.
Date Published: June 2009
Keywords:
View Abstract
Boccardi D, Menni S, La Vecchia C, et al. Overweight and childhood psoriasis. Br J Dermatol. 2009 Jun 9. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Brown BC, Warren RB, Grindlay DJ, et al. What's new in psoriasis? Analysis of the clinical significance of systematic reviews on psoriasis published in 2007 and 2008. Clin Exp Dermatol. 2009 Jun 30. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Chan CS, Van Voorhees AS, Lebwohl MG, et al. Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009 Jun;60(6):962-71.
Date Published: June 2009
Keywords:
View Abstract
Daudén E, Griffiths C, Ortonne JP, et al. Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks J Eur Acad Dermatol Venereol. 2009 Jun 26. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Duffin KC, Freeny IC, Schrodi SJ, et al. Association between IL13 Polymorphisms and Psoriatic Arthritis Is Modified by Smoking. J Invest Dermatol. 2009 Jun 25. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Emi Aikawa N, de Carvalho JF, Artur Almeida Silva C, et al. Immunogenicity of Anti-TNF-alpha Agents in Autoimmune Diseases. Clin Rev Allergy Immunol. 2009 Jun 30. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Farley E, Masrour S, McKey J, et al. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol. 2009 Jun;60(6):1024-31.
Date Published: June 2009
Keywords:
View Abstract
Gisondi P, Prignano F, Grossi P, et al. Dermatology Switzerland)". 2009 Jun 9. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Greiner RA, Braathen LR. Cost-effectiveness of biologics for moderate-to-severe psoriasis from the perspective of the Swiss healthcare system. Eur J Dermatol. 2009 Jun 5. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Heidenreich R, Röcken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol. 2009 Jun;90(3):232-48.
Date Published: June 2009
Keywords:
View Abstract
Jankovic S, Raznatovic M, Marinkovic J, et al. Risk factors for psoriasis: A case-control study. J Dermatol. 2009 Jun;36(6):328-34.
Date Published: June 2009
Keywords:
View Abstract
Kircik LH, Del Rosso JQ. Anti-TNF agents for the treatment of psoriasis. J Drugs Dermatol. 2009 Jun;8(6):546-59.
Date Published: June 2009
Keywords:
View Abstract
Loveman E, Turner D, Hartwell D, et al. Health Technol Assess England)". 2009 Jun;13 Suppl 1():55-60.
Date Published: June 2009
Keywords:
View Abstract
Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis Section . Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009 Jun 1. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Patel RV, Clark LN, Lebwohl M, et al. Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol. 2009 Jun;60(6):1001-17.
Date Published: June 2009
Keywords:
View Abstract
Prodanovich S, Kirsner RS, Kravetz JD, et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009 Jun;145(6):700-3.
Date Published: June 2009
Keywords:
View Abstract
Rashmi R, Rao KS, Basavaraj KH. A comprehensive review of biomarkers in psoriasis. Clin Exp Dermatol. 2009 Jun 25. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Sizto S, Bansback N, Feldman SR, et al. Economic evaluation of systemic therapies for moderate to severe psoriasis. Br J Dermatol. 2009 Jun;160(6):1264-72.
Date Published: June 2009
Keywords:
View Abstract
Tubach F, Salmon D, Ravaud P, et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry. Arthritis Rheum. 2009 Jun 29;60(7):1884-1894.
Date Published: June 2009
Keywords:
View Abstract
Ulusoy RE, Karabudak O, Yokusoglu M, et al. Noninvasive assessment of impaired endothelial function in psoriasis. Rheumatol Int. 2009 Jun 16. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Wain EM, Darling MI, Pleass RD, et al. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study. Br J Dermatol. 2009 Jun 12. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Woodley DT, Kim GH. Potential new insight into the pathogenesis of psoriasis. Arch Dermatol. 2009 Jun;145(6):713-4.
Date Published: June 2009
Keywords:
View Abstract
Xiao J, Chen LH, Tu YT, et al. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol. 2009 Jun 1. [Epub ahead of print]
Date Published: June 2009
Keywords:
View Abstract
Aggarwal R, Manadan AM, Poliyedath A, et al. Safety of etanercept in patients at high risk for mycobacterial tuberculosis infections. J Rheumatol. 2009 May;36(5):914-7.
Date Published: May 2009
Keywords:
View Abstract
Altobelli E, Petrocelli R, Maccarone M, et al. Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption. Eur J Dermatol. 2009 May 1;19(3):252-256.
Date Published: May 2009
Keywords:
View Abstract
Aujla SJ, Kolls JK. J Mol Med Germany)". 2009 May;87(5):451-4.
Date Published: May 2009
Keywords:
View Abstract
Brauchli YB, Jick SS, Miret M, et al. Psoriasis and Risk of Incident Cancer: An Inception Cohort Study with a Nested Case-Control Analysis. J Invest Dermatol. 2009 May 14. [Epub ahead of print]
Date Published: May 2009
Keywords:
View Abstract
Brauchli YB, Jick SS, Miret M, et al. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol. 2009 May;160(5):1048-56.
Date Published: May 2009
Keywords:
View Abstract
Brunasso AM, Massone C. Thrombocytopenia associated with the use of anti-tumor necrosis factor-alpha agents for psoriasis. J Am Acad Dermatol. 2009 May;60(5):781-5.
Date Published: May 2009
Keywords:
View Abstract
Cohen AD, Dreiher J, Birkenfeld S. Psoriasis associated with ulcerative colitis and Crohn's disease. J Eur Acad Dermatol Venereol. 2009 May;23(5):561-5.
Date Published: May 2009
Keywords:
View Abstract
El Shabrawi-Caelen L, La Placa M, Vincenzi C, et al. Adalimumab-induced psoriasis of the scalp with diffuse alopecia: A severe potentially irreversible cutaneous side effect of TNF-alpha blockers. Inflamm Bowel Dis. 2009 May 21. [Epub ahead of print]
Date Published: May 2009
Keywords:
View Abstract
Gelfand JM, Dommasch ED, Shin DB, et al. The Risk of Stroke in Patients with Psoriasis. J Invest Dermatol. 2009 May 21. [Epub ahead of print]
Date Published: May 2009
Keywords:
View Abstract
Gisondi P, Targher G, Zoppini G, et al. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009 May 27. [Epub ahead of print]
Date Published: May 2009
Keywords:
View Abstract
Gul U, Gonul M, Kaya I, et al. Autoimmune thyroid disorders in patients with psoriasis. Eur J Dermatol. 2009 May-Jun;19(3):221-3.
Date Published: May 2009
Keywords:
View Abstract
Ji J, Shu X, Sundquist K, et al. Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden. Br J Cancer. 2009 May 5;100(9):1499-502.
Date Published: May 2009
Keywords:
View Abstract
Johnson-Huang LM, McNutt NS, Krueger JG, et al. Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases. J Clin Immunol. 2009 May;29(3):247-56.
Date Published: May 2009
Keywords:
View Abstract
Kalb RE, Strober B, Weinstein G, et al. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol. 2009 May;60(5):824-37.
Date Published: May 2009
Keywords:
View Abstract
Kaymakcalan Z, Sakorafas P, Bose S, et al. Clin Immunol Fla.)". 2009 May;131(2):308-16.
Date Published: May 2009
Keywords:
View Abstract
Kleinpenning MM, Smits T, Boezeman J, et al. Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimens. Br J Dermatol. 2009 May 15. [Epub ahead of print]
Date Published: May 2009
Keywords:
View Abstract
Lindsay K, Fraser AD, Layton A, et al. Rheumatology (Oxford) England)". 2009 May;48(5):569-72.
Date Published: May 2009
Keywords:
View Abstract
Lonsdorf AS, Hwang ST, Enk AH. Chemokine Receptors in T-Cell-Mediated Diseases of the Skin. J Invest Dermatol. 2009 May 28. [Epub ahead of print]
Date Published: May 2009
Keywords:
View Abstract
Ortonne JP, Taïeb A, Ormerod AD, et al. Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept. Br J Dermatol. 2009 May 21. [Epub ahead of print]
Date Published: May 2009
Keywords:
View Abstract
Radtke MA, Reich K, Blome C, et al. Dermatology Switzerland)". 2009 May 7. [Epub ahead of print]
Date Published: May 2009
Keywords:
View Abstract
Rakkhit T, Panko JM, Christensen TE, et al. Plaque thickness and morphology in psoriasis vulgaris associated with therapeutic response. Br J Dermatol. 2009 May;160(5):1083-9.
Date Published: May 2009
Keywords:
View Abstract
Reich K, Krüger K, Mössner R, et al. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009 May;160(5):1040-7.
Date Published: May 2009
Keywords:
View Abstract
Reich K, Yasothan U, Kirkpatrick P. Ustekinumab. Nat Rev Drug Discov. 2009 May;8(5):355-6.
Date Published: May 2009
Keywords:
View Abstract
Tsiouri G, Gaitanis G, Kiorpelidou D, et al. Dermatology Switzerland)". 2009 May 28. [Epub ahead of print]
Date Published: May 2009
Keywords:
View Abstract
West K. CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders. Curr Opin Investig Drugs. 2009 May;10(5):491-504.
Date Published: May 2009
Keywords:
View Abstract
Witt CM, Lüdtke R, Willich SN. Homeopathic treatment of patients with psoriasis--a prospective observational study with 2 years follow-up. J Eur Acad Dermatol Venereol. 2009 May;23(5):538-43.
Date Published: May 2009
Keywords:
View Abstract
Wolk K, Haugen HS, Xu W, et al. J Mol Med Germany)". 2009 May;87(5):523-36.
Date Published: May 2009
Keywords:
View Abstract
Yawalkar N, Tscharner GG, Hunger RE, et al. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis. J Dermatol Sci. 2009 May;54(2):99-105.
Date Published: May 2009
Keywords:
View Abstract
Akama T, Baker SJ, Zhang YK, et al. Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2129-32.
Date Published: April 2009
Keywords:
View Abstract
Bagel J. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone. J Drugs Dermatol. 2009 Apr;8(4):351-7.
Date Published: April 2009
Keywords:
View Abstract
Bellet JS, Chamlin SL, Yan AC, et al. Intertriginous pustular psoriasis. J Am Acad Dermatol. 2009 Apr;60(4):679-83.
Date Published: April 2009
Keywords:
View Abstract
Brunasso AM, Salvini C, Massone C. Efalizumab for severe palmo-plantar psoriasis: an open-label pilot trial in five patients. J Eur Acad Dermatol Venereol. 2009 Apr;23(4):415-9.
Date Published: April 2009
Keywords:
View Abstract
Callis Duffin K, Wong B, Horn EJ, et al. Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis. J Am Acad Dermatol. 2009 Apr;60(4):604-8.
Date Published: April 2009
Keywords:
View Abstract
Caproni M, Volpi W, Chiarini C, et al. A case of natural killer cell monoclonal expansion during efalizumab treatment in a patient with psoriasis. Br J Dermatol. 2009 Apr;160(4):896-7.
Date Published: April 2009
Keywords:
View Abstract
Cohen P. Targeting protein kinases for the development of anti-inflammatory drugs. Curr Opin Cell Biol. 2009 Apr;21(2):317-24.
Date Published: April 2009
Keywords:
View Abstract
Collin B, Vani A, Ogboli M, et al. Methotrexate treatment in 13 children with severe plaque psoriasis. Clin Exp Dermatol. 2009 Apr;34(3):295-8.
Date Published: April 2009
Keywords:
View Abstract
Costanzo A, Talamonti M, Botti E, et al. Dermatology Switzerland)". 2009 Apr 16. [Epub ahead of print]
Date Published: April 2009
Keywords:
View Abstract
Duffin KC, Krueger GG. Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association. J Invest Dermatol. 2009 Apr;129(4):827-33.
Date Published: April 2009
Keywords:
View Abstract
Elder JT. Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. Genes Immun. 2009 Apr;10(3):201-9.
Date Published: April 2009
Keywords:
View Abstract
Fitch EL, Rizzo HL, Kurtz SE, et al. Inflammatory Skin Disease in K5.hTGF-beta1 Transgenic Mice Is Not Dependent on the IL-23/Th17 Inflammatory Pathway. J Invest Dermatol. 2009 Apr 9. [Epub ahead of print]
Date Published: April 2009
Keywords:
View Abstract
Gisondi P, Girolomoni G. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Semin Thromb Hemost. 2009 Apr;35(3):313-24.
Date Published: April 2009
Keywords:
View Abstract
Gladman DD, Schentag CT, Tom BD, et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis. 2009 Apr;68(4):497-501.
Date Published: April 2009
Keywords:
View Abstract
Jiménez-Puya R, Gómez-GarcÃa F, Amorrich-Campos V, et al. Etanercept: efficacy and safety. J Eur Acad Dermatol Venereol. 2009 Apr;23(4):402-5.
Date Published: April 2009
Keywords:
View Abstract
Kavanaugh A, McInnes I, Mease P, et al. Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum. 2009 Apr;60(4):976-86.
Date Published: April 2009
Keywords:
View Abstract
Lecluse LL, Tutein Nolthenius JL, Bos JD, et al. Patient preferences and satisfaction with systemic therapies for psoriasis: an area to be explored. Br J Dermatol. 2009 Apr 9. [Epub ahead of print]
Date Published: April 2009
Keywords:
View Abstract
Lozeron P, Denier C, Lacroix C, et al. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy. Arch Neurol. 2009 Apr;66(4):490-7.
Date Published: April 2009
Keywords:
View Abstract
Margolis D, Andrews E, Werther W. Follow: the Raptiva (efalizumab) Pregnancy Registry. J Am Acad Dermatol. 2009 Apr;60(4):705.
Date Published: April 2009
Keywords:
View Abstract
Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009 Apr;60(4):643-59.
Date Published: April 2009
Keywords:
View Abstract
Nair RP, Ding J, Duffin KC, et al. Psoriasis bench to bedside: genetics meets immunology. Arch Dermatol. 2009 Apr;145(4):462-4.
Date Published: April 2009
Keywords:
View Abstract
Papadavid E, Makris M, Dalamaga M, et al. Recall injection-site reactions to etanercept in a patient with psoriasis. Clin Exp Dermatol. 2009 Apr;34(3):414-5.
Date Published: April 2009
Keywords:
View Abstract
Patel RV, Clark LN, Lebwohl M, et al. Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol. 2009 Apr 1. [Epub ahead of print]
Date Published: April 2009
Keywords:
View Abstract
Pietrzak A, Kadzielewski J, Janowski K, et al. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity. Int J Dermatol. 2009 Apr;48(4):379-87.
Date Published: April 2009
Keywords:
View Abstract
Qureshi AA, Choi HK, Setty AR, et al. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol. 2009 Apr;145(4):379-82.
Date Published: April 2009
Keywords:
View Abstract
Rallis E, Verros C, Karanikola E, et al. Exacerbation of Psoriasis under Efalizumab Therapy. J Cutan Med Surg. 2009 Mar-Apr;13(2):106-9.
Date Published: April 2009
Keywords:
View Abstract
Schmid-Ott G, Jaeger B, Boehm T, et al. Immunological effects of stress in psoriasis. Br J Dermatol. 2009 Apr;160(4):782-5.
Date Published: April 2009
Keywords:
View Abstract
Takahashi H, Tsuji H, Takahashi I, et al. Prevalence of obesity/adiposity in Japanese psoriasis patients: adiposity is correlated with the severity of psoriasis. J Dermatol Sci. 2009 Apr;54(1):61-3.
Date Published: April 2009
Keywords:
View Abstract
Wakkee M, Nijsten T. Dermatol Clin Dermatologic clinics. "2009 Apr;27(2):137-47
Date Published: April 2009
Keywords:
View Abstract
Warren RB, Brown BC, Carmichael AJ, et al. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate. Clin Exp Dermatol. 2009 Apr;34(3):415-6.
Date Published: April 2009
Keywords:
View Abstract
Zippin JH. The genetics of psoriasis. J Drugs Dermatol. 2009 Apr;8(4):414-7.
Date Published: April 2009
Keywords:
View Abstract
Beyer M, Steinhoff M, Anagnostopoulos I, et al. Hepatosplenic T-cell lymphomas and therapy with TNF-alpha-blocking biologics: a risk for psoriasis patients? J Dtsch Dermatol Ges. 2009 Mar;7(3):191-4.
Date Published: March 2009
Keywords:
View Abstract
Caproni M, Antiga E, Melani L, et al. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. J Clin Immunol. 2009 Mar;29(2):210-4.
Date Published: March 2009
Keywords:
View Abstract
de Berker D. Management of psoriatic nail disease. Semin Cutan Med Surg. 2009 Mar;28(1):39-43.
Date Published: March 2009
Keywords:
View Abstract
Dediol I, Buljan M, Buljan D, et al. Association of psoriasis and alcoholism: psychodermatological issue. Psychiatr Danub. 2009 Mar;21(1):9-13.
Date Published: March 2009
Keywords:
View Abstract
Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis. J Invest Dermatol. 2009 Mar 26. [Epub ahead of print]
Date Published: March 2009
Keywords:
View Abstract
Driessen RJ, Boezeman JB, van de Kerkhof PC, et al. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome. Br J Dermatol. 2009 Mar;160(3):670-5.
Date Published: March 2009
Keywords:
View Abstract
Eedy DJ, Griffiths CE, Chalmers RJ, et al. Care of patients with psoriasis: an audit of U.K. services in secondary care. Br J Dermatol. 2009 Mar;160(3):557-64.
Date Published: March 2009
Keywords:
View Abstract
Eghlileb AM, Basra MK, Finlay AY. Dermatology Switzerland)". 2009 Mar 13. [Epub ahead of print]
Date Published: March 2009
Keywords:
View Abstract
Harper EG, Guo C, Rizzo H, et al. Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis. J Invest Dermatol. 2009 Mar 19. [Epub ahead of print]
Date Published: March 2009
Keywords:
View Abstract
Icen M, Crowson CS, McEvoy MT, et al. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009 Mar;60(3):394-401.
Date Published: March 2009
Keywords:
View Abstract
Li Y, Liao W, Chang M, et al. Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22. J Invest Dermatol. 2009 Mar;129(3):629-34.
Date Published: March 2009
Keywords:
View Abstract
Magin P, Adams J, Heading G, et al. Psychol Health Med health & medicine". 2009 Mar;14(2):150-61.
Date Published: March 2009
Keywords:
View Abstract
Mease PJ, Reich K. Alefacept with methotrexate for treatment of psoriatic arthritis: open-label extension of a randomized, double-blind, placebo-controlled study. J Am Acad Dermatol. 2009 Mar;60(3):402-11.
Date Published: March 2009
Keywords:
View Abstract
Miossec P. Diseases that may benefit from manipulating the Th17 pathway. Eur J Immunol. 2009 Mar;39(3):667-9.
Date Published: March 2009
Keywords:
View Abstract
Murray ML, Bergstresser PR, Adams-Huet B, et al. Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity. Clin Exp Dermatol. 2009 Mar;34(2):140-4.
Date Published: March 2009
Keywords:
View Abstract
Naldi L, Raho G. Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63.
Date Published: March 2009
Keywords:
View Abstract
Radtke M, Reich K, Blome C, et al. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol. 2009 Mar 4. [Epub ahead of print]
Date Published: March 2009
Keywords:
View Abstract
Sobell JM, Kalb RE, Weinberg JM. Management of moderate to severe plaque psoriasis (part 2): clinical update on T-cell modulators and investigational agents. J Drugs Dermatol. 2009 Mar;8(3):230-8.
Date Published: March 2009
Keywords:
View Abstract
Sobell JM, Weinberg JM. Patient fatalities potentially associated with efalizumab use. J Drugs Dermatol. 2009 Mar;8(3):215.
Date Published: March 2009
Keywords:
View Abstract
Strowd LC, Yentzer BA, Fleischer AB, et al. Increasing use of more potent treatments for psoriasis. J Am Acad Dermatol. 2009 Mar;60(3):478-81.
Date Published: March 2009
Keywords:
View Abstract
Watanabe H, Kawaguchi M, Fujishima S, et al. Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis. J Invest Dermatol. 2009 Mar;129(3):650-6.
Date Published: March 2009
Keywords:
View Abstract
Wu J, Chen F, Zhang X, et al. Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China. J Dermatol Sci. 2009 Mar;53(3):212-5.
Date Published: March 2009
Keywords:
View Abstract
Zane C, Capezzera R, Venturini M, et al. Dermatology Switzerland)". 2009 Mar 12. [Epub ahead of print]
Date Published: March 2009
Keywords:
View Abstract
[no authors listed]. Fungal nail infections: diagnosis and management. Prescrire Int. 2009 Feb;18(99):26-30.
Date Published: February 2009
Keywords:
View Abstract
Anderson KS, Wong J, Polyak K, et al. Detection of psoriasin/S100A7 in the sera of patients with psoriasis. Br J Dermatol. 2009 Feb;160(2):325-32.
Date Published: February 2009
Keywords:
View Abstract
Ashraf-Benson S, Wall GC, Veach LA. Serum sickness-like reaction associated with efalizumab. Ann Pharmacother. 2009 Feb;43(2):383-6.
Date Published: February 2009
Keywords:
View Abstract
Augustin M, Radtke M, van Engen A, et al. Pharmacoeconomic model of topical treatment options of mild to moderate psoriasis vulgaris in Germany. J Dtsch Dermatol Ges. 2009 Feb 10. [Epub ahead of print]
Date Published: February 2009
Keywords:
View Abstract
Blauvelt A, Bickenbach JR, Kulesz-Martin MF, et al. Montagna symposium 2008: the biologic basis of psoriasis. J Invest Dermatol. 2009 Feb;129(2):259-60.
Date Published: February 2009
Keywords:
View Abstract
Boy MG, Wang C, Wilkinson BE, et al. Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-690,550 in Patients With Psoriasis. J Invest Dermatol. 2009 Feb 19. [Epub ahead of print]
Date Published: February 2009
Keywords:
View Abstract
Chandran V. Epidemiology of psoriatic arthritis. J Rheumatol. 2009 Feb;36(2):213-5.
Date Published: February 2009
Keywords:
View Abstract
Chen YJ, Shen JL, Wu CY, et al. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis. J Am Acad Dermatol. 2009 Feb;60(2):225-30.
Date Published: February 2009
Keywords:
View Abstract
Cuchacovich RS, Espinoza LR. Ustekinumab for psoriatic arthritis. Lancet. 2009 Feb 21;373(9664):605-6.
Date Published: February 2009
Keywords:
View Abstract
D'Angelo S, Mennillo GA, Cutro MS, et al. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol. 2009 Feb;36(2):368-70.
Date Published: February 2009
Keywords:
View Abstract
Darabi K, Jaiswal R, Hostetler S, et al. Infectious complications in patients with psoriasis and rheumatoid arthritis treated with antitumor necrosis factor agents and methotrexate. J Drugs Dermatol. 2009 Feb;8(2):175-8.
Date Published: February 2009
Keywords:
View Abstract
de Cid R, Riveira-Munoz E, Zeeuwen PL, et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet. 2009 Feb;41(2):211-5.
Date Published: February 2009
Keywords:
View Abstract
Fitzgerald O, Winchester R. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther. 2009 Feb 12;11(1):214.
Date Published: February 2009
Keywords:
View Abstract
Fuchs I, Avnon L, Freud T, et al. Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors. Clin Rheumatol. 2009 Feb;28(2):167-72.
Date Published: February 2009
Keywords:
View Abstract
Gottlieb A, Menter A, Mendelsohn A, et al. Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet. 2009 Feb 21;373(9664):633-40.
Date Published: February 2009
Keywords:
View Abstract
Harrison MJ, Dixon WG, Watson KD, et al. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2009 Feb;68(2):209-15.
Date Published: February 2009
Keywords:
View Abstract
Hüffmeier U, Lascorz J, Böhm B, et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol. 2009 Feb;129(2):355-8.
Date Published: February 2009
Keywords:
View Abstract
Jain S, Kaur IR, Das S, et al. T helper 1 to T helper 2 shift in cytokine expression: an autoregulatory process in superantigen-associated psoriasis progression? J Med Microbiol. 2009 Feb;58(Pt 2):180-4.
Date Published: February 2009
Keywords:
View Abstract
Jin Y, Yang S, Zhang F, et al. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China. J Eur Acad Dermatol Venereol. 2009 Feb;23(2):132-7.
Date Published: February 2009
Keywords:
View Abstract
Johansen C, Usher PA, Kjellerup RB, et al. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol. 2009 Feb;160(2):319-24.
Date Published: February 2009
Keywords:
View Abstract
Kalyoncu U, Gossec L, Nguyen M, et al. spine : revue du rhumatisme" bone. 2009 Feb 11. [Epub ahead of print]
Date Published: February 2009
Keywords:
View Abstract
Kato T, Tsunemi Y, Saeki H, et al. Interferon-18 gene polymorphism -137 G/C is associated with susceptibility to psoriasis vulgaris but not with atopic dermatitis in Japanese patients. J Dermatol Sci. 2009 Feb;53(2):162-3.
Date Published: February 2009
Keywords:
View Abstract
Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol. 2009 Feb;60(2):218-24.
Date Published: February 2009
Keywords:
View Abstract
Leithead JA, Simpson KJ, MacGilchrist AJ. Fulminant hepatic failure following overdose of the vitamin A metabolite acitretin. Eur J Gastroenterol Hepatol. 2009 Feb;21(2):230-2.
Date Published: February 2009
Keywords:
View Abstract
Lloyd A, Reeves P, Conway P, et al. Economic evaluation of etanercept in the management of chronic plaque psoriasis. Br J Dermatol. 2009 Feb;160(2):380-6.
Date Published: February 2009
Keywords:
View Abstract
Mease PJ. Assessing the impact of psoriatic arthritis on patient function and quality of life: lessons learned from other rheumatologic conditions. Semin Arthritis Rheum. 2009 Feb;38(4):320-35.
Date Published: February 2009
Keywords:
View Abstract
Nair RP, Duffin KC, Helms C, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009 Feb;41(2):199-204.
Date Published: February 2009
Keywords:
View Abstract
Nast A, Spuls P, Ormerod A, et al. A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: 'AGREE-ing' on a common base for European evidence-based psoriasis treatment guidelines. J Eur Acad Dermatol Venereol. 2009 Feb 24. [Epub ahead of print]
Date Published: February 2009
Keywords:
View Abstract
Nograles KE, Brasington RD, Bowcock AM. New insights into the pathogenesis and genetics of psoriatic arthritis. Nat Clin Pract Rheumatol. 2009 Feb;5(2):83-91.
Date Published: February 2009
Keywords:
View Abstract
Nossent JC, Gran JT. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway. Scand J Rheumatol. 2009 Feb 26. [Epub ahead of print]
Date Published: February 2009
Keywords:
View Abstract
Olivieri I, D'Angelo S, Palazzi C, et al. Treatment strategies for early psoriatic arthritis. Expert Opin Pharmacother. 2009 Feb;10(2):271-82.
Date Published: February 2009
Keywords:
View Abstract
Phung OJ, Coleman CI, Kugelman L, et al. The impact of biologic agents to treat plaque psoriasis. Conn Med. 2009 Feb;73(2):79-83.
Date Published: February 2009
Keywords:
View Abstract
Prpi?-Massari L, Kastelan M. Innate and acquired immunity in psoriasis. Arch Dermatol Res. 2009 Feb;301(2):195-6.
Date Published: February 2009
Keywords:
View Abstract
Rigopoulos D, Gregoriou S, Daniel Iii CR, et al. Dermatology Switzerland)". 2009 Feb 12. [Epub ahead of print]
Date Published: February 2009
Keywords:
View Abstract
Shibata S, Saeki H, Tsunemi Y, et al. IL-17F single nucleotide polymorphism is not associated with psoriasis vulgaris or atopic dermatitis in the Japanese population. J Dermatol Sci. 2009 Feb;53(2):163-5.
Date Published: February 2009
Keywords:
View Abstract
Sobell JM, Kalb RE, Weinberg JM. Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents. J Drugs Dermatol. 2009 Feb;8(2):147-54.
Date Published: February 2009
Keywords:
View Abstract
Stenderup K, Rosada C, Worsaae A, et al. Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model. Br J Dermatol. 2009 Feb;160(2):284-96.
Date Published: February 2009
Keywords:
View Abstract
Verhoeven EW, Kraaimaat FW, Jong EM, et al. Effect of Daily Stressors on Psoriasis: A Prospective Study. J Invest Dermatol. 2009 Feb 5. [Epub ahead of print]
Date Published: February 2009
Keywords:
View Abstract
Warren RB, Smith RL, Campalani E, et al. Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms. Br J Dermatol. 2009 Feb;160(2):438-41.
Date Published: February 2009
Keywords:
View Abstract
Wilson FC, Icen M, Crowson CS, et al. Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. J Rheumatol. 2009 Feb;36(2):361-7.
Date Published: February 2009
Keywords:
View Abstract
Wilson FC, Icen M, Crowson CS, et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009 Feb 15;61(2):233-9.
Date Published: February 2009
Keywords:
View Abstract
Zaba LC, Krueger JG, Lowes MA. "Resident and ""inflammatory"" dendritic cells in human skin." J Invest Dermatol. 2009 Feb;129(2):302-8.
Date Published: February 2009
Keywords:
View Abstract
Zhang XJ, Huang W, Yang S, et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet. 2009 Feb;41(2):205-10.
Date Published: February 2009
Keywords:
View Abstract
Zhu Y, Hu C, Lu M, et al. Population pharmacokinetic modeling of ustekinumab, a human monoclonal antibody targeting IL-12/23p40, in patients with moderate to severe plaque psoriasis. J Clin Pharmacol. 2009 Feb;49(2):162-75.
Date Published: February 2009
Keywords:
View Abstract
Antonucci A, Bardazzi F, Balestri R, et al. Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases. J Dermatolog Treat. 2009;20(1):61-2.
Date Published: January 2009
Keywords:
View Abstract
Balci DD, Balci A, Karazincir S, et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol. 2009 Jan;23(1):1-6.
Date Published: January 2009
Keywords:
View Abstract
Berthelot JM, De Bandt M, Goupille P, et al. spine : revue du rhumatisme" bone. 2009 Jan;76(1):28-34.
Date Published: January 2009
Keywords:
View Abstract
Brunasso AM, Delfino C, Massone C. Dermatology Switzerland)". 2009;218(1):73-4.
Date Published: January 2009
Keywords:
View Abstract
Bruzzese V, Pepe J. Efficacy of cyclosporine in the treatment of a case of infliximab-induced erythrodermic psoriasis. Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):235-8.
Date Published: January 2009
Keywords:
View Abstract
Burmester GR, Mease PJ, Dijkmans BA, et al. Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Ann Rheum Dis. 2009 Jan 15. [Epub ahead of print]
Date Published: January 2009
Keywords:
View Abstract
Castelo-Soccio L, Van Voorhees AS. Long-term efficacy of biologics in dermatology. Dermatol Ther. 2009 Jan-Feb;22(1):22-33.
Date Published: January 2009
Keywords:
View Abstract
Channual J, Wu JJ, Dann FJ. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis. Dermatol Ther. 2009 Jan-Feb;22(1):61-73.
Date Published: January 2009
Keywords:
View Abstract
Costanzo A, Talamonti M, Spallone G, et al. Dermatology Switzerland)". 2009;218(2):146-50.
Date Published: January 2009
Keywords:
View Abstract
Croom KF, McCormack PL. Adalimumab: in plaque psoriasis. Am J Clin Dermatol. 2009;10(1):43-50.
Date Published: January 2009
Keywords:
View Abstract
De Jager ME, Van De Kerkhof PC, De Jong EM, et al. Epidemiology and prescribed treatments in childhood psoriasis: A survey among medical professionals. J Dermatolog Treat. 2009 Jan 1. [Epub ahead of print]
Date Published: January 2009
Keywords:
View Abstract
De Leeuw J, Van Lingen RG, Both H, et al. A comparative study on the efficacy of treatment with 585 nm pulsed dye laser and ultraviolet B-TL01 in plaque type psoriasis. Dermatol Surg. 2009 Jan;35(1):80-91.
Date Published: January 2009
Keywords:
View Abstract
Dreiher J, Weitzman D, Cohen AD. Psoriasis and Osteoporosis: A Sex-Specific Association? J Invest Dermatol. 2009 Jan 22. [Epub ahead of print]
Date Published: January 2009
Keywords:
View Abstract
Driessen RJ, Boezeman JB, Van De Kerkhof PC, et al. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. J Dermatolog Treat. 2009;20(1):42-7.
Date Published: January 2009
Keywords:
View Abstract
Einarsdottir E, Koskinen LL, Dukes E, et al. IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet. 2009;10():8.
Date Published: January 2009
Keywords:
View Abstract
English PL, Vender R. Occurrence of plantar pustular psoriasis during treatment with infliximab. J Cutan Med Surg. 2009 Jan-Feb;13(1):40-2.
Date Published: January 2009
Keywords:
View Abstract
Esposito M, Mazzotta A, Saraceno R, et al. Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis. Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):219-25.
Date Published: January 2009
Keywords:
View Abstract
Federman DG, Shelling M, Prodanovich S, et al. Psoriasis: an opportunity to identify cardiovascular risk. Br J Dermatol. 2009 Jan;160(1):1-7.
Date Published: January 2009
Keywords:
View Abstract
Frampton JE, Plosker GL. Efalizumab: a review of its use in the management of chronic moderate-to-severe plaque psoriasis. Am J Clin Dermatol. 2009;10(1):51-72.
Date Published: January 2009
Keywords:
View Abstract
Gattu S, Rashid RM, Wu JJ. 308-nm excimer laser in psoriasis vulgaris, scalp psoriasis, and palmoplantar psoriasis. J Eur Acad Dermatol Venereol. 2009 Jan;23(1):36-41.
Date Published: January 2009
Keywords:
View Abstract
George D, Rosen T. Treatment of inverse psoriasis with efalizumab. J Drugs Dermatol. 2009 Jan;8(1):74-6.
Date Published: January 2009
Keywords:
View Abstract
Gisondi P, Fantin F, Del Giglio M, et al. Dermatology Switzerland)". 2009;218(2):110-3.
Date Published: January 2009
Keywords:
View Abstract
Gladman DD. Psoriatic arthritis. Dermatol Ther. 2009 Jan-Feb;22(1):40-55.
Date Published: January 2009
Keywords:
View Abstract
Hernandez C, Worobec SM, Gaitonde SS, et al. Progression of undiagnosed cutaneous T-cell lymphoma during efalizumab therapy. Arch Dermatol. 2009 Jan;145(1):92-4.
Date Published: January 2009
Keywords:
View Abstract
Idriss SZ, Kvedar JC, Watson AJ. The role of online support communities: benefits of expanded social networks to patients with psoriasis. Arch Dermatol. 2009 Jan;145(1):46-51.
Date Published: January 2009
Keywords:
View Abstract
Irla N, Yawalkar N. Marked improvement in nail psoriasis during treatment with adalimumab. Dermatology. 2009;219(4):353-6.
Date Published: January 2009
Keywords:
View Abstract
Jean J, Lapointe M, Soucy J, et al. Development of an in vitro psoriatic skin model by tissue engineering. J Dermatol Sci. 2009 Jan;53(1):19-25.
Date Published: January 2009
Keywords:
View Abstract
Kalb RE, Bagel J, Korman NJ, et al. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009 Jan;60(1):120-4.
Date Published: January 2009
Keywords:
View Abstract
Kanikowska A, Kramer L, Pawlaczyk M. Quality of life in Polish patients with psoriasis. J Eur Acad Dermatol Venereol. 2009 Jan;23(1):92-3.
Date Published: January 2009
Keywords:
View Abstract
Karanikas E, Harsoulis F, Giouzepas I, et al. Neuroendocrine stimulatory tests of hypothalamus-pituitary-adrenal axis in psoriasis and correlative implications with psychopathological and immune parameters. J Dermatol. 2009 Jan;36(1):35-44.
Date Published: January 2009
Keywords:
View Abstract
Kirshen C, Kanigsberg N. Alopecia areata following adalimumab. J Cutan Med Surg. 2009 Jan-Feb;13(1):48-50.
Date Published: January 2009
Keywords:
View Abstract
Kitamura G, Mehr N, Anderson N, et al. A case of tuberculosis in a patient on Efalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis. Dermatol Online J. 2009;15(2):11.
Date Published: January 2009
Keywords:
View Abstract
Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J Dermatolog Treat. 2009;20(2):100-8.
Date Published: January 2009
Keywords:
View Abstract
Kop EN, Körver JE, Van Ruysevelt D, et al. Erythroderma in two patients with psoriasis upon discontinuation of efalizumab treatment. J Dermatolog Treat. 2009;20(1):67-9.
Date Published: January 2009
Keywords:
View Abstract
Kramer JM, Turner JE. Efalizumab therapy for psoriasis in patients with inadequate responses to etanercept. Am J Clin Dermatol. 2009;10(2):134-40.
Date Published: January 2009
Keywords:
View Abstract
Kulkarni AS, Horn E, Balkrishnan R, et al. Severity levels in psoriasis: a separate 'very severe' category not required. J Dermatolog Treat. 2009;20(1):48-51.
Date Published: January 2009
Keywords:
View Abstract
Kunz M, Ibrahim SM. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm. 2009;2009():979258.
Date Published: January 2009
Keywords:
View Abstract
Lee JY. Severe 20-nail psoriasis successfully treated by low dose methotrexate. Dermatol Online J. 2009;15(11):8.
Date Published: January 2009
Keywords:
View Abstract
Lekpa FK, Economu-Dubosc A, Fevre C, et al. Efficacy of etanercept in lymphedema associated with psoriatic arthritis. J Rheumatol. 2009 Jan;36(1):207-8.
Date Published: January 2009
Keywords:
View Abstract
Leung YY, Tam LS, Lee KW, et al. Rheumatology (Oxford) England)". 2009 Jan;48(1):53-6.
Date Published: January 2009
Keywords:
View Abstract
Lora V, Gisondi P, Calza A, et al.. Efficacy of a single educative intervention in patients with chronic plaque psoriasis. Dermatology. 2009;219(4):316-21.
Date Published: January 2009
Keywords:
View Abstract
Lucas J, Ntuen E, Pearce DJ, et al. Methotrexate: Understanding the risk in psoriasis patients. J Dermatolog Treat. 2009 Jan 1. [Epub ahead of print]
Date Published: January 2009
Keywords:
View Abstract
Lynde C. Use of biologic therapeutics in difficult-to-treat psoriasis. J Cutan Med Surg. 2009 Jan-Feb;13(1):6-17.
Date Published: January 2009
Keywords:
View Abstract
Noiles K, Vender R. Nail psoriasis and biologics. J Cutan Med Surg. 2009 Jan-Feb;13(1):1-5.
Date Published: January 2009
Keywords:
View Abstract
Perlmutter A, Mittal A, Menter A. Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians. Br J Dermatol. 2009 Jan;160(1):8-15.
Date Published: January 2009
Keywords:
View Abstract
Poole CD, Conway P, Currie CJ. Rheumatology (Oxford) England)". 2009 Jan;48(1):78-82.
Date Published: January 2009
Keywords:
View Abstract
Rahman P, Inman RD, Maksymowych WP, et al. Association of interleukin 23 receptor variants with psoriatic arthritis. J Rheumatol. 2009 Jan;36(1):137-40.
Date Published: January 2009
Keywords:
View Abstract
Reich K, Segaert S, Van de Kerkhof P, et al.. Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis. Dermatology. 2009;219(3):239-49.
Date Published: January 2009
Keywords:
View Abstract
Rozenblit M, Lebwohl M. New biologics for psoriasis and psoriatic arthritis. Dermatol Ther. 2009 Jan-Feb;22(1):56-60.
Date Published: January 2009
Keywords:
View Abstract
Ruiz-Villaverde R, Sánchez-Cano D, Abalos-Medina G. Adolescent plaque psoriasis: Our experience using etanercept. J Eur Acad Dermatol Venereol. 2009 Jan 13. [Epub ahead of print]
Date Published: January 2009
Keywords:
View Abstract
Sheth N, Greenblatt DT, Acland K, et al. Generalized pustular psoriasis of pregnancy treated with infliximab. Clin Exp Dermatol. 2009 Jan 12. [Epub ahead of print]
Date Published: January 2009
Keywords:
View Abstract
Sieper J. Developments in the scientific and clinical understanding of the spondyloarthritides. Arthritis Res Ther. 2009 Jan 30;11(1):208.
Date Published: January 2009
Keywords:
View Abstract
Silverberg NB. Pediatric psoriasis: an update. Ther Clin Risk Manag. 2009;5():849-56.
Date Published: January 2009
Keywords:
View Abstract
Sterry W, Bagot M, Ferrandiz C, et al. Immunosuppressive therapy in dermatology and PML. J Dtsch Dermatol Ges. 2009 Jan;7(1):5.
Date Published: January 2009
Keywords:
View Abstract
Sukhatme SV, Gottlieb AB. Pediatric psoriasis: updates in biologic therapies. Dermatol Ther. 2009 Jan-Feb;22(1):34-9.
Date Published: January 2009
Keywords:
View Abstract
Taylor SL, Petrie M, O'Rourke KS, et al. Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms. J Dermatolog Treat. 2009 Jan 1. [Epub ahead of print]
Date Published: January 2009
Keywords:
View Abstract
Tsuruta D. NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat Inflamm Allergy Drug Discov. 2009;3(1):40-8.
Date Published: January 2009
Keywords:
View Abstract
van de Kerkhof PC, Hoffmann V, Anstey A, et al. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. Br J Dermatol. 2009 Jan;160(1):170-6.
Date Published: January 2009
Keywords:
View Abstract
Vena GA, Galluccio A, De Simone C, et al. A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite project. Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):227-33.
Date Published: January 2009
Keywords:
View Abstract
Warren RB, Brown BC, Lavery D, et al. Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre. Br J Dermatol. 2009 Jan;160(1):162-9.
Date Published: January 2009
Keywords:
View Abstract
Weber J, Keam SJ. Ustekinumab. BioDrugs. 2009;23(1):53-61.
Date Published: January 2009
Keywords:
View Abstract
Wolf P, Hofer A, Legat FJ, et al. Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept. Br J Dermatol. 2009 Jan;160(1):186-9.
Date Published: January 2009
Keywords:
View Abstract
Wolkenstein P, Revuz J, Roujeau JC, et al. Dermatology Switzerland)". 2009;218(2):103-9.
Date Published: January 2009
Keywords:
View Abstract
Wolkenstein P, Revuz J, Roujeau JC, et al. Dermatology Switzerland)". 2009;218(2):103-9.
Date Published: January 2009
Keywords:
View Abstract
Yawalkar N, Hunger RE. Dermatology Switzerland)". 2009;218(1):79-83.
Date Published: January 2009
Keywords:
View Abstract
Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol. 2009 Jan;129(1):79-88.
Date Published: January 2009
Keywords:
View Abstract
Alcaide AJ, Barrera MV, Habicheyn S, et al. Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection. J Eur Acad Dermatol Venereol. 2008 Dec;22(12):1514-6.
Date Published: December 2008
Keywords:
View Abstract
Bartlett BL, Moody MN, Tyring SK. IL-12/IL-23 Inhibitors: The Advantages and Disadvantages of this Novel Approach for the Treatment of Psoriasis. Skin Therapy Lett. 2008 Dec;13(8):1-4.
Date Published: December 2008
Keywords:
View Abstract
Boniface K, Blom B, Liu YJ, et al. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev. 2008 Dec;226():132-46.
Date Published: December 2008
Keywords:
View Abstract
Brauchli YB, Jick SS, Meier CR. Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol. 2008 Dec;159(6):1331-7.
Date Published: December 2008
Keywords:
View Abstract
Chen YJ, Wu CY, Shen JL, et al. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol. 2008 Dec;144(12):1571-5.
Date Published: December 2008
Keywords:
View Abstract
Collazo MH, González JR, Torres EA. Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant. P R Health Sci J. 2008 Dec;27(4):346-7.
Date Published: December 2008
Keywords:
View Abstract
Conway P, Currie CJ. Descriptive epidemiology of hospitalisation for psoriasis. Curr Med Res Opin. 2008 Dec;24(12):3487-91.
Date Published: December 2008
Keywords:
View Abstract
Cuchacovich R, Espinoza CG, Virk Z, et al. Biologic therapy (TNF-alpha antagonists)-induced psoriasis: a cytokine imbalance between TNF-alpha and IFN-alpha? J Clin Rheumatol. 2008 Dec;14(6):353-6.
Date Published: December 2008
Keywords:
View Abstract
Dalaker M, Bonesrønning JH. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort. J Eur Acad Dermatol Venereol. 2008 Dec 19. [Epub ahead of print]
Date Published: December 2008
Keywords:
View Abstract
Domm S, Cinatl J, Mrowietz U. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature. Br J Dermatol. 2008 Dec;159(6):1217-28.
Date Published: December 2008
Keywords:
View Abstract
Feld J, Weiss G, Rosner I, et al. Electrocardiographic findings in psoriatic arthritis: a case-controlled study. J Rheumatol. 2008 Dec;35(12):2379-82.
Date Published: December 2008
Keywords:
View Abstract
Feldman SR, Horn EJ, Balkrishnan R, et al. Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol. 2008 Dec;59(6):1009-16.
Date Published: December 2008
Keywords:
View Abstract
Filer C, Ho P, Smith RL, et al. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum. 2008 Dec;58(12):3705-9.
Date Published: December 2008
Keywords:
View Abstract
Friedewald VE, Cather JC, Gelfand JM, et al. AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol. 2008 Dec 15;102(12):1631-43.
Date Published: December 2008
Keywords:
View Abstract
Gladman DD. Can we identify psoriatic arthritis early? Curr Rheumatol Rep. 2008 Dec;10(6):419-21.
Date Published: December 2008
Keywords:
View Abstract
Hu SW, Holt EW, Husni ME, et al. Willingness-to-Pay Stated Preferences for 8 Health-Related Quality-of-Life Domains in Psoriatic Arthritis: A Pilot Study. Semin Arthritis Rheum. 2008 Dec 16. [Epub ahead of print]
Date Published: December 2008
Keywords:
View Abstract
Kaur S, Zilmer K, Kairane C, et al. Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis. Br J Dermatol. 2008 Dec;159(6):1364-7.
Date Published: December 2008
Keywords:
View Abstract
Lecluse LL, Naldi L, Stern RS, et al. Dermatology Switzerland)". 2008 Dec 11. [Epub ahead of print]
Date Published: December 2008
Keywords:
View Abstract
Leman J, Burden A. Treatment of severe psoriasis with infliximab. Ther Clin Risk Manag. 2008 Dec;4(6):1165-76.
Date Published: December 2008
Keywords:
View Abstract
Magin PJ, Pond CD, Smith WT, et al. A cross-sectional study of psychological morbidity in patients with acne, psoriasis and atopic dermatitis in specialist dermatology and general practices. J Eur Acad Dermatol Venereol. 2008 Dec;22(12):1435-44.
Date Published: December 2008
Keywords:
View Abstract
Menter A, Reich K, Gottlieb AB, et al. Adverse drug events in infliximab-treated patients compared with the general and psoriasis populations. J Drugs Dermatol. 2008 Dec;7(12):1137-46.
Date Published: December 2008
Keywords:
View Abstract
Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008 Dec;159(6):1245-66.
Date Published: December 2008
Keywords:
View Abstract
Noiles K, Vender R. Treatment of severe facial psoriasis with adalimumab. J Drugs Dermatol. 2008 Dec;7(12):1165-7.
Date Published: December 2008
Keywords:
View Abstract
Puig L, Roé E, GarcÃa-Navarro X, et al. Efalizumab treatment of psoriasis vulgaris: a cohort study in outpatient clinical practice. Clin Exp Dermatol. 2008 Dec 2. [Epub ahead of print]
Date Published: December 2008
Keywords:
View Abstract
Schmidt C. Ustekinumab poised to enter the psoriasis market. Nat Biotechnol. 2008 Dec;26(12):1317-8.
Date Published: December 2008
Keywords:
View Abstract
Smith RL, Eyre S, Warren RB, et al. No association between polymorphisms in the interleukin-15 gene and early-onset psoriasis in a UK cohort suggests heterogeneity for this susceptibility locus identified in Chinese psoriasis patients. J Invest Dermatol. 2008 Dec;128(12):2904-5.
Date Published: December 2008
Keywords:
View Abstract
Wu EQ, Feldman SR, Chen L, et al. Utilization pattern of etanercept and its cost implications in moderate to severe psoriasis in a managed care population. Curr Med Res Opin. 2008 Dec;24(12):3493-501.
Date Published: December 2008
Keywords:
View Abstract
Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, et al. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol. 2008;181:7420-7
Date Published: November 2008
Keywords:
View Abstract
Yawalkar N, Hunger RE. Successful Treatment of Recalcitrant Palmoplantar Pustular Psoriasis with Sequential Use of Infliximab and Adalimumab. Dermatology. 2008;[Epub ahead of print]
Date Published: October 2008
Keywords:
View Abstract
Costanzo A, Talamonti M, Spallone G, et al. Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy. Dermatology. 2008;[Epub ahead of print]
Date Published: October 2008
Keywords:
View Abstract
Roé E, Puig L, Corella F, et al. Cutaneous adverse effects of biological therapies for psoriasis. Eur J Dermatol. 2008;[Epub ahead of print]
Date Published: October 2008
Keywords:
View Abstract
Ritchlin CT, Kavanaugh A, Gladman DD, et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis. 2008;[Epub ahead of print]
Date Published: October 2008
Keywords:
View Abstract
Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases. J Dermatolog Treat. 2008;[Epub ahead of print]
Date Published: October 2008
Keywords:
View Abstract
Duffin KC, Krueger GG. Genetic Variations in Cytokines and Cytokine Receptors Associated with Psoriasis Found by Genome-Wide Association. J Invest Dermatol. 2008;[Epub ahead of print]
Date Published: October 2008
Keywords:
View Abstract
Revicki DA, Menter A, Feldman S, et al. Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study. Health Qual Life Outcomes. 2008;6:75
Date Published: October 2008
Keywords:
View Abstract
Revicki DA, Menter A, Feldman S, et al. Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study. Health Qual Life Outcomes. 2008;6:75
Date Published: October 2008
Keywords:
View Abstract
Watanabe H, Kawaguchi M, Fujishima S, et al. Functional Characterization of IL-17F as a Selective Neutrophil Attractant in Psoriasis. J Invest Dermatol. 2008;[Epub ahead of print]
Date Published: October 2008
Keywords:
View Abstract
Feldman SR, Horn EJ, Balkrishnan R, et al. Psoriasis: Improving adherence to topical therapy. J Am Acad Dermatol. 2008;[Epub ahead of print]
Date Published: October 2008
Keywords:
View Abstract
Kryczek I, Bruce AT, Gudjonsson JE, et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol. 2008;181:4733-41
Date Published: October 2008
Keywords:
View Abstract
DE Oliveira JP, Levy A, Morel P, et al. Efficacy of infliximab for severe recalcitrant psoriasis after 6 weeks of treatment. J Dermatol. 2008;35:575-80
Date Published: September 2008
Keywords:
View Abstract
Janowski K, Pietrzak A. Indications for psychological intervention in patients with psoriasis. Dermatol Ther. 2008;21:409-11
Date Published: September 2008
Keywords:
View Abstract
Carter JD, Gerard HC, Hudson AP. Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum. Ann Rheum Dis. 2008;67:1181-3
Date Published: August 2008
Keywords:
View Abstract
Doherty SD, Van Voorhees A, Lebwohl MG, et al. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents J Am Acad Dermatol. 2008;59:209-17
Date Published: August 2008
Keywords:
View Abstract
Lucas A, Belinchón I, Pérez-Crespo M, et al. Successful response to narrow-band UVB in a patient undergoing concomitant treatment with adalimumab for psoriasis. Australas J Dermatol. 2008;49:173-4
Date Published: August 2008
Keywords:
View Abstract
Martinez-Hervas S, Fandos M, Real JT, et al. Insulin resistance and oxidative stress in familial combined hyperlipidemia. Atherosclerosis. 2008;199:384-9
Date Published: August 2008
Keywords:
View Abstract
Mensah KA, Schwarz EM, Ritchlin CT. Altered bone remodeling in psoriatic arthritis. Curr Rheumatol Rep. 2008;10:311-7
Date Published: August 2008
Keywords:
View Abstract
Piccolo D, Cesare AD, Fargnoli MC, et al. Effective control of psoriasis by etanercept in a patient with HCV-related diseases Eur J Dermatol. 2008;18:459-60 [Epub]
Date Published: August 2008
Keywords:
View Abstract
Yip L, Harrison S, Foley P. From biologic to biologic to biologic: lessons to learn for erythrodermic and recalcitrant chronic plaque psoriasis. Australas J Dermatol. 2008;49:152-5
Date Published: August 2008
Keywords:
View Abstract
Garcia VE, Chang M, Brandon R, et al. Detailed genetic characterization of the interleukin-23 receptor in psoriasis. Genes Immun. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Hollis-Moffatt JE, Merriman ME, Rodger RA, et al. Evidence for association of an interleukin-23 receptor variant independent of the R381Q variant with rheumatoid arthritis. Ann Rheum Dis. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Driessen RJ, Boezeman JB, Van de Kerkhof PC, et al. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. J Dermatolog Treat. 2008;[Epub ahead of print]:1-5.
Date Published: July 2008
Keywords:
View Abstract
Yang L, Anderson DE, Baecher-Allan C, et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells Nature. 2008;454:350-2
Date Published: July 2008
Keywords:
View Abstract
Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, et al. Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells. J Invest Dermatol. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Asarch A, Barak O, Loo DS, et al. Th17 cells: A new paradigm for cutaneous inflammation. J Dermatolog Treat. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Collamer AN, Guerrero KT, Henning JS, et al. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action Arthritis Rheum. 2008;59:996-1001
Date Published: July 2008
Keywords:
View Abstract
Dreiher J, Weitzman D, Shapiro J, et al. Psoriasis and chronic obstructive pulmonary disease: a case-control study. Br J Dermatol. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Asarch A, Barak O, Loo DS, et al.. Th17 cells: A new therapeutic target in inflammatory dermatoses. J Dermatolog Treat. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Samoud-El Kissi S, Galai Y, Sghiri R, et al. BAFF is elevated in serum of patients with psoriasis: association with disease activity. Br J Dermatol. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Antonucci A, Bardazzi F, Balestri R, et al. Efalizumab-associated papular psoriasis: An adverse reaction to efalizumab in three cases. J Dermatolog Treat. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Yentzer BA, Yelverton CB, Pearce DJ, et al. Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis. J Am Acad Dermatol. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Driessen RJ, de Jong EM, de Rie MA, et al. Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis. Br J Dermatol. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Feldman SR, Gottlieb AB, Bala M, et al. Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis. Br J Dermatol. 2008;[Epub agead of print]
Date Published: July 2008
Keywords:
View Abstract
Lecluse LL, Piskin G, Mekkes JR, et al. Review and expert opinion on prevention and treatment of infliximab-related infusion reactions. Br J Dermatol. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Schmitt J, Zhang Z, Wozel G, et al. Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br J Dermatol. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Bordel-Gómez M, Sánchez-Estella J, MartÃnez-González O, et al. Palmoplantar psoriasis: a paradoxical adverse reaction induced by adalimumab. J Eur Acad Dermatol Venereol. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: a systematic review J Rheumatol. 2008;35:1354-8
Date Published: July 2008
Keywords:
View Abstract
Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology Curr Opin Rheumatol. 2008;20:416-22
Date Published: July 2008
Keywords:
View Abstract
Boehncke WH, Adebajo A, Cauli A, et al. Initiative for Quality in Psoriasis and Psoriatic Arthritis J Rheumatol. 2008;35:1431-1433
Date Published: July 2008
Keywords:
View Abstract
Boyle DL, Kavanaugh A. The pathobiology of psoriatic synovium Curr Opin Rheumatol. 2008;20:404-7
Date Published: July 2008
Keywords:
View Abstract
Christopher GF, Meires J. Treating acute onset of psoriasis Nurse Pract. 2008;33:7-10
Date Published: July 2008
Keywords:
View Abstract
Coates LC, Anderson RR, Fitzgerald O, et al. Clues to the Pathogenesis of Psoriasis and Psoriatic Arthritis from Imaging: A Literature Review J Rheumatol. 2008;35:1438-1442
Date Published: July 2008
Keywords:
View Abstract
De Vlam K, Gottlieb AB, Fitzgerald O. Biological Biomarkers in Psoriatic Disease. A Review. J Rheumatol. 2008;35:1443-1448
Date Published: July 2008
Keywords:
View Abstract
Elder JT, Rahman P. Genetics of Psoriasis and Psoriatic Arthritis: Update and Future Direction. J Rheumatol. 2008;35:1449-1453
Date Published: July 2008
Keywords:
View Abstract
Gladman DD. GRAPPA 2007: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis -- Prologue J Rheumatol. 2008;35:1420-2
Date Published: July 2008
Keywords:
View Abstract
Gladman DD, Rahman P, Krueger GG, et al. Clinical and Genetic Registries in Psoriatic Disease. J Rheumatol. 2008;35:1458-1463
Date Published: July 2008
Keywords:
View Abstract
Hussain W, Coulson I, Owen C. Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients Clin Exp Dermatol. 2008;33:520-2
Date Published: July 2008
Keywords:
View Abstract
Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol. 2008;[Epub ahead of print]
Date Published: July 2008
Keywords:
View Abstract
Kop EN, Korver JE, Van Ruysevelt D, et al. Erythroderma in two patients with psoriasis upon discontinuation of efalizumab treatment. J Dermatolog Treat. 2008;24:1-3
Date Published: July 2008
Keywords:
View Abstract
Kulkarni AS, Horn E, Balkrishnan R, et al. Severity levels in psoriasis: A separate 'very severe' category not required. J Dermatolog Treat. 2008;24:1-3
Date Published: July 2008
Keywords:
View Abstract
Lindsay K, Gough A. Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk? Rheumatology. 2008;47:939-41
Date Published: July 2008
Keywords:
View Abstract
Mease PJ. Assessment tools in psoriatic arthritis J Rheumatol. 2008;35:1426-30
Date Published: July 2008
Keywords:
Nair RP, Ruether A, Stuart PE, et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol. 2008;128:1653-61
Date Published: July 2008
Keywords:
View Abstract
Nijsten T, Spuls PI. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis Br J Dermatol. 2008;159(1):257-8
Date Published: July 2008
Keywords:
View Abstract
Qureshi AA, Dominguez P, Duffin KC, et al. Psoriatic Arthritis Screening Tools J Rheumatol. 2008;35:1423-1425
Date Published: July 2008
Keywords:
View Abstract
Rabin RL, Levinson AI. The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature. Clin Exp Immunol. 2008;153:19-30
Date Published: July 2008
Keywords:
View Abstract
Ritchlin C, Tausk F. Centers for psoriasis: a comprehensive approach to patient care, education and research Curr Opin Rheumatol. 2008;20:381-3
Date Published: July 2008
Keywords:
View Abstract
Ritchlin CT. From skin to bone: translational perspectives on psoriatic disease J Rheumatol. 2008;35:1434-7
Date Published: July 2008
Keywords:
View Abstract
Routhouska SB, Sheth PB, Korman NJ. Long-term management of generalized pustular psoriasis with infliximab: case series. J Cutan Med Surg. 2008;12:184-8
Date Published: July 2008
Keywords:
View Abstract
Taylor WJ, Korendowych E, Nash P, et al. Drug Use and Toxicity in Psoriatic Disease: Focus on Methotrexate. J Rheumatol. 2008;35:1454-1457
Date Published: July 2008
Keywords:
View Abstract
Zell D, Hu S, Kirsner R. Genetic alterations in psoriasis J Invest Dermatol. 2008;128:1614
Date Published: July 2008
Keywords:
View Abstract
Wakkee M, Lugtenberg M, Spuls PI, et al. Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists. Br J Dermatol. 2008;[Epub ahead of print]
Date Published: June 2008
Keywords:
View Abstract
Smith RL, Eyre S, Warren RB, et al. No Association between Polymorphisms in the Interleukin-15 Gene and Early-Onset Psoriasis in a UK Cohort Suggests Heterogeneity for this Susceptibility Locus Identified in Chinese Psoriasis Patients J Invest Dermatol. 2008[Epub ahead of print]
Date Published: June 2008
Keywords:
View Abstract
Jin Y, Zhang F, Yang S, et al. Combined effects of HLA-Cw6, body mass index and waist-hip ratio on psoriasis vulgaris in Chinese Han population J Dermatol Sci. 2008;[Epub ahead of print]
Date Published: June 2008
Keywords:
View Synopsis View Abstract
Nast A, Reytan N, Rosumeck S, et al. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry. J Eur Acad Dermatol Venereol. 2008;[Epub ahead of print]
Date Published: June 2008
Keywords:
View Abstract
Rigopoulos D, Gregoriou S, Stratigos A, et al. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study Br J Dermatol. 2008;[Epub ahead of print]
Date Published: June 2008
Keywords:
View Abstract
Boehncke WH, Boehncke S. Research in practice: the systemic aspects of psoriasis J Dtsch Dermatol Ges. 2008;[Epub ahead of print]
Date Published: June 2008
Keywords:
View Abstract
Driessen RJ, van de Kerkhof PC, de Jong EM. Etanercept combined with methotrexate for high-need psoriasis Br J Dermatol. 2008;[Epub ahead of print]
Date Published: June 2008
Keywords:
View Abstract
Johnston A, Arnadottir S, Gudjonsson JE, et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation Br J Dermatol. 2008:[Epub ahead of print]
Date Published: June 2008
Keywords:
View Abstract
Brimhall AK, King LN, Licciardone JC, et al. Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials Br J Dermatol. 2008;[Epub ahead of print]
Date Published: June 2008
Keywords:
View Abstract
Ahmadi A, Barikbin B, Naseri M, et al. The effect of HESA-A on psoriasis vulgaris. J Drugs Dermatol. 2008;7:559-61
Date Published: June 2008
Keywords:
View Abstract
Berg M, Svensson M, Brandberg M, et al. Psoriasis and stress: a prospective study. J Eur Acad Dermatol Venereol. 2008;22:670-4
Date Published: June 2008
Keywords:
View Abstract
Borrás-Blasco J, Gracia-Perez A, Nuñez-Cornejo C, et al. Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab J Clin Pharm Ther. 2008;33:321-5
Date Published: June 2008
Keywords:
View Abstract
Gisondi P, Del Giglio M, Cotena C, et al. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. Br J Dermatol. 2008;158:1345-9
Date Published: June 2008
Keywords:
View Abstract
Goldberg LD. The convergence of psoriasis treatment cost-effectiveness over time: "real world" considerations in economic modeling J Am Acad Dermatol. 2008;58:1073-5
Date Published: June 2008
Keywords:
View Abstract
Gottlieb AB, Dann F, Menter A. Psoriasis and the metabolic syndrome J Drugs Dermatol. 2008;7:563-72
Date Published: June 2008
Keywords:
View Abstract
Huang W, Cordoro KM, Taylor SL, et al. To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis. J Am Acad Dermatol. 2008;58:970-7
Date Published: June 2008
Keywords:
View Abstract
Kimball AB, Gladman D, Gelfand JM, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008;58:1031-42
Date Published: June 2008
Keywords:
View Abstract
Kwan JM, Reese AM, Trafeli JP. Delayed autoimmune hemolytic anemia in efalizumab-treated psoriasis. J Am Acad Dermatol. 2008;58:1053-5
Date Published: June 2008
Keywords:
View Abstract
Lehman JS, Rahil AK. Congenital psoriasis: case report and literature review Pediatr Dermatol. 2008;25:332-8
Date Published: June 2008
Keywords:
View Abstract
Oh ST, Schramme A, Stark A, et al. Overexpression of ADAM 10 and ADAM 12 in lesional psoriatic skin. Br J Dermatol. 2008;158:1371-3
Date Published: June 2008
Keywords:
View Abstract
Patel V, Horn EJ, Lobosco SJ, et al. Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists. J Am Acad Dermatol. 2008;58:964-9
Date Published: June 2008
Keywords:
View Abstract
Ravindran V, Scott DL, Choy EH. A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis. Ann Rheum Dis. 2008;67:855-9
Date Published: June 2008
Keywords:
View Abstract
Tesmer LA, Lundy SK, Sarkar S, et al. Th17 cells in human disease. Immunol Rev. 2008;223:87-113
Date Published: June 2008
Keywords:
View Abstract
Van L, Modi SV, Yang DJ, et al. Sustained efficacy and safety of adalimumab in psoriasis treatment: a retrospective study of 49 patients with and without a history of TNF-alpha antagonist treatment Arch Dermatol. 2008;144:804-6
Date Published: June 2008
Keywords:
View Abstract
Viguier M, Richette P, Aubin F, et al. Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis Arthritis Rheum. 2008;58:1796-802
Date Published: June 2008
Keywords:
View Abstract
Cohen AD, Dreiher J, Shapiro Y, et al. Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol. 2008;22:585-9
Date Published: May 2008
Keywords:
View Abstract
Strober B, Teller C, Yamauchi P, et al. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis Br J Dermatol. 2008;[Epub ahead of print]
Date Published: May 2008
Keywords:
View Abstract
Bartlett BL, Tyring SK. Ustekinumab for chronic plaque psoriasis Lancet. 2008;371(9625):1639-40
Date Published: May 2008
Keywords:
View Abstract
Leonardi CL, Kimball AB, Papp KA, et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) Lancet. 2008;371(9625):1665-74
Date Published: May 2008
Keywords:
View Abstract
Papp KA, Langley RG, Lebwohl M, et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) Lancet. 2008;371:1675-84
Date Published: May 2008
Keywords:
View Abstract
Young CN, Koepke JI, Terlecky LJ, et al. Reactive Oxygen Species in Tumor Necrosis Factor-alpha-Activated Primary Human Keratinocytes: Implications for Psoriasis and Inflammatory Skin Disease J Invest Dermatol. 2008;[Epub ahead of print]
Date Published: May 2008
Keywords:
View Abstract
Antoni CE, Kavanaugh A, van der Heijde D, et al. Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). J Rheumatol. 2008;35:869-76
Date Published: May 2008
Keywords:
View Abstract
Balato A, La Bella S, Gaudiello F, et al. Efalizumab-induced guttate psoriasis. Successful management and re-treatment J Dermatolog Treat. 2008;19:182-4
Date Published: May 2008
Keywords:
View Abstract
Blauvelt A. T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis. J Invest Dermatol. 2008;128:1064-7
Date Published: May 2008
Keywords:
View Abstract
Cordoro KM. Systemic and light therapies for the management of childhood psoriasis: part II. Skin Therapy Lett. 2008;13:1-3
Date Published: May 2008
Keywords:
View Abstract
Ding C, Xu J, Li J. ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases Curr Opin Investig Drugs. 2008;9:515-22
Date Published: May 2008
Keywords:
View Abstract
Driessen RJ, Berends MA, Boezeman JB, et al. Psoriasis treatment with etanercept and efalizumab: clinical strategies influencing treatment outcome. Br J Dermatol. 2008;158:1098-106
Date Published: May 2008
Keywords:
View Abstract
Gelfand JM, Kimball AB, Mostow EN, et al. Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment Value Health. 2008;11:400-7
Date Published: May 2008
Keywords:
View Abstract
Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58:851-64
Date Published: May 2008
Keywords:
View Abstract
Guttman-Yassky E, Vugmeyster Y, Lowes MA, et al. Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness. J Invest Dermatol. 2008;128:1182-91
Date Published: May 2008
Keywords:
View Abstract
Ho PY, Barton A, Worthington J, et al. Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis. 2008;67:677-82
Date Published: May 2008
Keywords:
View Abstract
Kircik L, Bagel J, Korman N, et al. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes. J Drugs Dermatol. 2008;7:245-53
Date Published: May 2008
Keywords:
View Abstract
Krueger GG, Gottlieb AB, Sterry W. A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis J Dermatolog Treat. 2008;19:146-55
Date Published: May 2008
Keywords:
View Abstract
Landells I, MacCallum C, Khraishi M. The role of the dermatologist in identification and treatment of the early stages of psoriatic arthritis. Skin Therapy Lett. 2008;13:4-7
Date Published: May 2008
Keywords:
View Abstract
Leonardi C, Menter A, Hamilton T, et al. Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis. Br J Dermatol. 2008;158:1107-16
Date Published: May 2008
Keywords:
View Abstract
Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol. 2008;128:1207-11
Date Published: May 2008
Keywords:
View Abstract
Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826-50
Date Published: May 2008
Keywords:
View Synopsis View Abstract
Ohtsuka T. The relation between high-sensitivity C-reactive protein and maximum body mass index in patients with psoriasis. Br J Dermatol. 2008;158:1141-3
Date Published: May 2008
Keywords:
View Abstract
Piccirillo F, Stinco G, Patrone P. Erythrodermic psoriasis successfully treated with efalizumab Eur J Dermatol. 2008;18:357-8
Date Published: May 2008
Keywords:
View Abstract
Reich K, Sinclair R, Roberts G, et al. Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis. Curr Med Res Opin. 2008;24:1237-54
Date Published: May 2008
Keywords:
View Abstract
Saraceno R, Chimenti S.. How to manage infections in the era of biologics? Dermatol Ther.. 2008;21:180-6
Date Published: May 2008
Keywords:
View Abstract
Shelling ML, Federman DG, Prodanovich S, et al. Psoriasis and vascular disease: an unsolved mystery Am J Med. 2008;121:360-5
Date Published: May 2008
Keywords:
View Abstract
Smith EC, Riddle C, Menter MA, et al. Combining systemic retinoids with biologic agents for moderate to severe psoriasis. Int J Dermatol. 2008;47:514-8
Date Published: May 2008
Keywords:
View Abstract
Smith RL, Warren RB, Eyre S, et al. Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. J Invest Dermatol. 2008;128:1325-7
Date Published: May 2008
Keywords:
View Abstract
Smith RL, Warren RB, Eyre S, et al. Polymorphisms in the PTPN22 region are associated with psoriasis of early onset. Br J Dermatol. 2008;158:962-8
Date Published: May 2008
Keywords:
View Abstract
Wakkee M, Thio HB, Spuls PI, et al. Evaluation of the reimbursement criteria for biological therapies for psoriasis in the Netherlands. Br J Dermatol. 2008;158:1159-61
Date Published: May 2008
Keywords:
View Abstract
Wang Y, Chen J, Zhao Y, et al. Psoriasis is associated with increased levels of serum leptin. Br J Dermatol. 2008;158:1134-5
Date Published: May 2008
Keywords:
View Abstract
Wendling D, Balblanc JC, Briançon D, et al. Onset or exacerbation of cutaneous psoriasis during TNFalpha antagonist therapy. Joint Bone Spine. 2008;75:315-8
Date Published: May 2008
Keywords:
View Abstract
Zangrilli A, Papoutsaki M, Talamonti M, et al. Long-term efficacy of adalimumab in generalized pustular psoriasis J Dermatolog Treat. 2008;19:185-7
Date Published: May 2008
Keywords:
View Abstract
Gladman DD, Schentag CT, Tom BD, et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: The Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis. 2008; [Epub ahead of print]
Date Published: April 2008
Keywords:
View Abstract
Van Lingen RG, De Jong EM, Berends MA, et al. Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: A pilot study J Dermatolog Treat. 2008;[Epub ahead of print]
Date Published: April 2008
Keywords:
View Abstract
Naldi L. The search for effective and safe disease control in psoriasis. Lancet. 2008;371:1311-2
Date Published: April 2008
Keywords:
View Abstract
Colsman A, Carrascosa JM, Ferrandiz C, et al. Successful treatment of recalcitrant palmoplantar psoriasis with efalizumab. J Eur Acad Dermatol Venereol. 2008;[Epub ahead of print]
Date Published: April 2008
Keywords:
View Abstract
Harrison MJ, Dixon WG, Watson KD, et al. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-TNF{alpha} therapy. Results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2008;[Epub ahead of print]
Date Published: April 2008
Keywords:
View Abstract
Bal A, Gurcay E, Aydog E, et al. Onset of psoriasis induced by infliximab. J Clin Rheumatol. 2008;14:128-9
Date Published: April 2008
Keywords:
View Abstract
Balato N, Ayala F, Gaudiello F, et al. Comparison of tuberculin skin test and interferon-gamma assays in patients with moderate to severe psoriasis who are candidates for antitumour necrosis factor-alpha therapy. Br J Dermatol. 2008;158:847-9
Date Published: April 2008
Keywords:
View Abstract
Bosch RI, Amo Ndel V, Manteca CF, et al. Psoriasis induced by anti-TNF probably not so uncommon. J Clin Rheumatol. 2008;14:128
Date Published: April 2008
Keywords:
View Abstract
Capsoni F, Ongari AM, Frigerio E, et al. Effect of Efalizumab on neutrophil and monocyte functions in patients with psoriasis Int J Immunopathol Pharmacol. 2008;21:437-45
Date Published: April 2008
Keywords:
View Abstract
Ducharme E, Weinberg JM. Etanercept.
Expert Opin Biol Ther. 2008;8:491-502
Date Published: April 2008
Keywords:
View Abstract
Friedewald VE Jr, Cather JC, Gordon KB, et al. The editor's roundtable: psoriasis, inflammation, and coronary artery disease. Am J Cardiol. 2008;101:1119-26
Date Published: April 2008
Keywords:
View Abstract
Kanikowska A, Kramer L, Pawlaczyk M. Quality of life in Polish patients with psoriasis. J Eur Acad Dermatol Venereol. 2008;[Epub ahead of print]
Date Published: April 2008
Keywords:
View Abstract
Krell J, Nelson C, Spencer L, et al. An open-label study evaluating the efficacy and tolerability of alefacept for the treatment of scalp psoriasis. J Am Acad Dermatol. 2008;58:609-16
Date Published: April 2008
Keywords:
View Abstract
Lindqvist UR, Alenius GM, Husmark T, et al. The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis. J Rheumatol. 2008;35:668-73
Date Published: April 2008
Keywords:
View Abstract
Mikhail M, Weinberg JM, Smith BL. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus. Arch Dermatol. 2008; 144:453-6
Date Published: April 2008
Keywords:
View Abstract
Osborne JE, Hutchinson PE. Demographic and clinical correlates of extent of psoriasis during stable disease and during flares in chronic plaque psoriasis. Br J Dermatol. 2008;158:721-6
Date Published: April 2008
Keywords:
View Abstract
Saraceno R, Schipani C, Mazzotta A, et al. Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis. Pharmacol Res. 2008;57:290-5. Epub 2008 Feb 29
Date Published: April 2008
Keywords:
View Synopsis View Abstract
Ulmer A, Wölbing F, Metzler G, et al. Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic management. Br J Dermatol. 2008;158:867-9
Date Published: April 2008
Keywords:
View Abstract
Wu Y, Mills D, Bala M. Psoriasis: cardiovascular risk factors and other disease comorbidities J Drugs Dermatol. 2008;7(4):373-7
Date Published: April 2008
Keywords:
View Abstract
Liu Y, Helms C, Liao W, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008;4:e1000041
Date Published: March 2008
Keywords:
View Abstract
Larios G, Alevizos A, Rigopoulos D. Risk of psoriasis and obesity in women. Arch Intern Med. 2008;168:666
Date Published: March 2008
Keywords:
View Abstract
Fan X, Yang S, Huang W, et al. Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese population. PLoS Genet. 2008;4:e1000038
Date Published: March 2008
Keywords:
View Abstract
Alcaide AJ, Barrera MV, Habicheyn S, et al. Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection. J Eur Acad Dermatol Venereol. 2008:[Epub ahead of print]
Date Published: March 2008
Keywords:
View Abstract
Kimball AB, Robinson D Jr, Wu Y, et al. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology. 2008;217:27-37
Date Published: March 2008
Keywords:
View Abstract
Varma R, Cantrell W, Elmets C, et al. Infliximab for the treatment of severe pustular psoriasis: 6 years later. J Eur Acad Dermatol Venereol. 2008:[Epub ahead of print]
Date Published: March 2008
Keywords:
View Abstract
Augustin M, Krüger K, Radtke MA, et al. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology. 2008;216(4):366-72
Date Published: March 2008
Keywords:
View Abstract
Adisen E, Karaca F, Gürer MA. When there is no single best biological agent: psoriasis and psoriatic arthritis in the same patient responding to two different biological agents. Clin Exp Dermatol. 2008;33:164-6
Date Published: March 2008
Keywords:
View Abstract
Alstergren P, Larsson PT, Kopp S. Successful treatment with multiple intra-articular injections of infliximab in a patient with psoriatic arthritis. Scand J Rheumatol. 2008;37:155-7
Date Published: March 2008
Keywords:
View Abstract
Ammoury A, El Sayed F, Dhaybi R, et al. Palmoplantar pustulosis should not be considered as a variant of psoriasis. J Eur Acad Dermatol Venereol. 2008;22:392-3
Date Published: March 2008
Keywords:
View Abstract
F, Tengattini S, Fabiano A, et al. Atherosclerosis and oxidative stress. Histol Histopathol. 2008;23:381-90
Date Published: March 2008
Keywords:
View Abstract
Brauchli YB, Jick SS, Curtin F, et al. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study. J Am Acad Dermatol. 2008;58:421-9
Date Published: March 2008
Keywords:
View Abstract
Cafardi JA, Cantrell W, Wang W, et al. The safety and efficacy of high-dose alefacept compared with a loading dose of alefacept in patients with chronic plaque psoriasis. Skinmed. 2008;7:67-72.
Date Published: March 2008
Keywords:
View Abstract
Carr D, Tusa MG, Carroll CL, et al. Open label trial of alefacept in palmoplantar pustular psoriasis J Dermatolog Treat. 2008;19:97-100
Date Published: March 2008
Keywords:
View Abstract
Christophers E. Explaining phenotype heterogeneity in patients with psoriasis. Br J Dermatol. 2008;158:437-41
Date Published: March 2008
Keywords:
View Abstract
Clark L, Lebwohl M. The effect of weight on the efficacy of biologic therapy in patients with psoriasis. J Am Acad Dermatol. 2008;58:443-6
Date Published: March 2008
Keywords:
View Abstract
Galindo MP, Bartlett BL, Gewirtzman A, et al. Etanercept: an overview of its role in the treatment of psoriasis. Expert Opin Drug Metab Toxicol. 2008;4:305-10
Date Published: March 2008
Keywords:
View Abstract
Gisondi P, Cotena C, Tessari G, et al. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. J Eur Acad Dermatol Venereol. 2008;22:341-4
Date Published: March 2008
Keywords:
View Abstract
Gokdemir G, Ari S, Köslü A. Adherence to treatment in patients with psoriasis vulgaris: Turkish experience. J Eur Acad Dermatol Venereol. 2008;22:330-5
Date Published: March 2008
Keywords:
View Abstract
Haider AS, Cohen J, Fei J, et al. Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome. J Invest Dermatol. 2008;128:655-66
Date Published: March 2008
Keywords:
View Abstract
Heidenreich R, Röcken M, Ghoreschi K. Angiogenesis: the new potential target for the therapy of psoriasis? Drug News Perspect. 2008;21:97-105
Date Published: March 2008
Keywords:
View Abstract
Helliwell PS, Taylor WJ; CASPAR Study Group. Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions. J Rheumatol. 2008;35:472-6
Date Published: March 2008
Keywords:
View Abstract
Heymann WR. Psoriasis: the heart of the matter. J Am Acad Dermatol. 2008;58:477-8
Date Published: March 2008
Keywords:
View Abstract
Mössner R, Thaci D, Mohr J, et al. Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases. Arch Dermatol Res. 2008;300:101-5
Date Published: March 2008
Keywords:
View Abstract
Ormerod AD. Adalimumab: a new alternative biologic agent for chronic plaque psoriasis. Br J Dermatol. 2008;158:435-6
Date Published: March 2008
Keywords:
View Abstract
Papadavid E, Gazi S, Dalamaga M, et al. Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management. J Eur Acad Dermatol Venereol. 2008;22:380-2
Date Published: March 2008
Keywords:
View Abstract
Papoutsaki M, Costanzo A, Chimenti MS, et al. Adalimumab for the treatment of severe psoriasis and psoriatic arthritis. Expert Opin Biol Ther. 2008;8:363-70
Date Published: March 2008
Keywords:
View Abstract
Rallis E, Anyfantakis V. Coexistent psoriasis and bullous pemphigoid responding to mycophenolate mofetil monotherapy. Skinmed. 2008;7:101-2
Date Published: March 2008
Keywords:
View Abstract
Rallis E, Stavropoulou E, Rigopoulos D. Rapid response of nail psoriasis to etanercept. J Rheumatol. 2008;35:544-5
Date Published: March 2008
Keywords:
View Abstract
Revicki D, Willian MK, Saurat JH, et al. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br J Dermatol. 2008;158:549-57
Date Published: March 2008
Keywords:
View Abstract
Saurat JH, Stingl G, Dubertret L, et al. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol. 2008;158:558-66
Date Published: March 2008
Keywords:
View Abstract
Tsai TF, Liu MT, Liao YH, et al. Clinical effectiveness and safety experience with efalizumab in the treatment of patients with moderate-to-severe plaque psoriasis in Taiwan: results of an open-label, single-arm pilot study. J Eur Acad Dermatol Venereol. 2008;22:345-52
Date Published: March 2008
Keywords:
View Abstract
Tzu J, Kerdel F. From conventional to cutting edge: the new era of biologics in treatment of psoriasis. Dermatol Ther. 2008;21:131-41
Date Published: March 2008
Keywords:
View Abstract
Huang PH, Liao YH, Wei CC, et al. Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate-to-severe chronic plaque psoriasis in Taiwan: results of an open-label, single-arm, multicentre pilot study. J Eur Acad Dermatol Venereol. 2008:[Epub ahead of print]
Date Published: February 2008
Keywords:
View Abstract
Mease PJ. Assessing the Impact of Psoriatic Arthritis on Patient Function and Quality of Life: Lessons Learned from Other Rheumatologic Conditions. Semin Arthritis Rheum. 2008:[Epub ahead of print]
Date Published: February 2008
Keywords:
View Abstract
Esposito M, Mazzotta A, Casciello C, et al. Etanercept at different dosages in the treatment of generalized pustular psoriasis: a case series. Dermatology. 2008;216:355-60
Date Published: February 2008
Keywords:
View Abstract
Dehnavi R, de Roos A, Rabelink TJ, et al. Elevated CRP levels are associated with increased carotid atherosclerosis independent of visceral obesity. Atherosclerosis. 2008 Feb 18. [Epub ahead of print]
Date Published: February 2008
Keywords:
View Abstract
Haider AS, Lowes MA, Suárez-Fariñas M, et al. Identification of cellular pathways of "type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol. 2008;180:1913-20
Date Published: February 2008
Keywords:
View Abstract
Kimball AB, Gordon KB, Langley RG, et al. Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial. Arch Dermatol. 2008;144:200-7
Date Published: February 2008
Keywords:
View Abstract
Kourosh AS, Miner A, Menter A. Psoriasis as the marker of underlying systemic disease. Skin Therapy Lett. 2008;13:1-5
Date Published: February 2008
Keywords:
View Abstract
Ma HL, Liang S, Li J, et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest. 2008;118:597-607
Date Published: February 2008
Keywords:
View Abstract
Oiso N, Yamadori Y, Higashimori N, et al. Allergic contact dermatitis caused by sesame oil in a topical Chinese medicine, shi-un-ko. Contact Dermatitis. 2008;58:109
Date Published: February 2008
Keywords:
View Abstract
Rich P, Griffiths CE, Reich K, et al. Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol. 2008;58:224-31
Date Published: February 2008
Keywords:
View Abstract
Sergeant A, Makrygeorgou A, Chan WC, et al. C-reactive protein in psoriasis. Br J Dermatol. 2008;158:417-9
Date Published: February 2008
Keywords:
View Abstract
Strober B, Teller C, Yamauchi P, et al. C-reactive protein levels in patients with psoriasis and psoriatic arthritis: effects of etanercept therapy. Presented at: 66th Annual Meeting of the American Academy of Dermatology. February 2008; San Antonio, Tex. Presentation P2623.
Date Published: February 2008
Keywords:
Paller AS, Siegfried EC, Langley RG, et al. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med. 2008;358:241-51
Date Published: January 2008
Keywords:
View Abstract
Ackermann C, Kavanaugh A. Economic burden of psoriatic arthritis. Pharmacoeconomics. 2008;26:121-9
Date Published: January 2008
Keywords:
View Abstract
Barde C, Thielen AM, Saurat JH. Infliximab then efalizumab, the 'hit and run' approach does not work. Dermatology. 2008;216:171-2
Date Published: January 2008
Keywords:
View Abstract
Ciocon DH, Horn EJ, Kimball AB. Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only : results of the 2005 Spring US National Psoriasis Foundation Survey. Am J Clin Dermatol. 2008;9:111-7
Date Published: January 2008
Keywords:
View Abstract
Cohen AD, Sherf M, Vidavsky L, et al. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology. 2008;216:152-5
Date Published: January 2008
Keywords:
View Abstract
Corrao S, Puleo A, Pistone G, et al. No evidence-based practice by biased information from systematic reviews: the case of etanercept and infliximab for the treatment of psoriatic arthritis. Clin Exp Rheumatol. 2008;26:164
Date Published: January 2008
Keywords:
View Abstract
Flytström I, Stenberg B, Svensson A, et al. Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial. Br J Dermatol. 2008;158:116-121
Date Published: January 2008
Keywords:
View Abstract
Gomez-Gallego M, Meca-Lallana J, Fernandez-Barreiro A, et al. Multiple sclerosis onset during etanercept treatment. Eur Neurol. 2008;59:91-3
Date Published: January 2008
Keywords:
View Abstract
Gottlieb AB, Chao C, Dann F. Psoriasis comorbidities. J Dermatolog Treat. 2008;19:5-21
Date Published: January 2008
Keywords:
View Abstract
Guilhou JJ, Molès JP. New hypotheses in the genetics of psoriasis and other 'complex' diseases. Dermatology. 2008;216:87-92
Date Published: January 2008
Keywords:
View Abstract
Hamilton T, Menter A, Caro I, et al. Safety of Efalizumab Therapy in Patients with Moderate to Severe Psoriasis: An Open-Label Extension of a Phase IIIb Trial. Drug Saf. 2008;31:715-26
Date Published: January 2008
Keywords:
View Abstract
Menter A, Tyring SK, Gordon K, et al. Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. J Am Acad Dermatol. 2008;58:106-15
Date Published: January 2008
Keywords:
View Abstract
Menter A, Tyring SK, Gordon K, et al. Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. J Am Acad Dermatol. 2008;58:106-15
Date Published: January 2008
Keywords:
View Abstract
Nelson AA, Pearce DJ, Fleischer AB Jr, et al. Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period. J Am Acad Dermatol. 2008;58:125-35
Date Published: January 2008
Keywords:
View Abstract
Olivieri I, D'Angelo S, Padula A, et al. The challenge of early diagnosis of psoriatic arthritis. J Rheumatol. 2008;35:3-5
Date Published: January 2008
Keywords:
View Abstract
Perlmutter A, Cather J, Franks B, et al. Alefacept revisited: Our 3-year clinical experience in 200 patients with chronic plaque psoriasis. J Am Acad Dermatol. 2008;58:116-24
Date Published: January 2008
Keywords:
View Abstract
Pitarch G, Sánchez-Carazo JL, Mahiques L, et al. Efficacy of etanercept in psoriatic patients previously treated with infliximab. Dermatology. 2008;216:312-6
Date Published: January 2008
Keywords:
View Abstract
Revicki DA, Willian MK, Menter A, et al. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis. Dermatology. 2008;216:260-70
Date Published: January 2008
Keywords:
View Abstract
Rohekar S, Tom BD, Hassa A, et al. Prevalence of malignancy in psoriatic arthritis. Arthritis Rheum. 2008;58:82-7
Date Published: January 2008
Keywords:
View Abstract
Sayre RM, Dowdy JC. The increase in melanoma: are dietary furocoumarins responsible? Med Hypotheses. 2008;70:855-9
Date Published: January 2008
Keywords:
View Abstract
Scarpa R, Cuocolo A, Peluso R, et al. Early psoriatic arthritis: the clinical spectrum. J Rheumatol. 2008;35:137-41
Date Published: January 2008
Keywords:
View Abstract
Schmitt-Egenolf M. Switching biologicals: switching TNFalpha antagonists in psoriasis treatment. Dermatology. 2008;216:281-2
Date Published: January 2008
Keywords:
View Abstract
Stinco G, Piccirillo F, Patrone P. Treatment of palmoplantar pustular psoriasis with efalizumab: a quick response with early recurrence. Eur J Dermatol. 2008;18:91-2
Date Published: January 2008
Keywords:
View Abstract
Thas JJ. Siddha medicine--background and principles and the application for skin diseases. Clin Dermatol. 2008;26:62-78
Date Published: January 2008
Keywords:
View Abstract
Van de Kerkhof PC. Psoriasis more than skin deep. J Dermatolog Treat. 2008;19:4
Date Published: January 2008
Keywords:
View Abstract
Varma R, Cafardi JA, Cantrell W, et al. Safety and efficacy of subcutaneously administered efalizumab in adults with moderate-to-severe hand and foot psoriasis: an open-label study. Am J Clin Dermatol. 2008;9:105-9
Date Published: January 2008
Keywords:
View Abstract
Vieira Serrão V, Martins A, Lopes MJ. Infliximab in recalcitrant generalized pustular arthropatic psoriasis. Eur J Dermatol. 2008;18:71-3
Date Published: January 2008
Keywords:
View Abstract
Wozel G, Vitez L. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab. Acta Derm Venereol. 2008;88:169-70
Date Published: January 2008
Keywords:
View Abstract
Hueber AJ, McInnes IB. Immune regulation in psoriasis and psoriatic arthritis--recent developments. Immunol Lett. 2007;114:59-65
Date Published: December 2007
Keywords:
View Abstract
Boehncke S, Thaci D, Beschmann H, et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol. 2007;157:1249-51
Date Published: December 2007
Keywords:
View Abstract
Boniface K, Guignouard E, Pedretti N, et al. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol. 2007;150:407-15
Date Published: December 2007
Keywords:
View Abstract
Guttman-Yassky E, Krueger JG. Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research. Br J Dermatol. 2007;157:1103-15
Date Published: December 2007
Keywords:
View Abstract
Guttman-Yassky E, Krueger JG. Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research. Br J Dermatol. 2007;157:1103-1115
Date Published: December 2007
Keywords:
View Abstract
Hick J, Feldman SR. Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments. J Am Acad Dermatol. 2007;57:972-6
Date Published: December 2007
Keywords:
View Abstract
Horn EJ, Fox KM, Patel V, et al. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol. 2007;57:957-62
Date Published: December 2007
Keywords:
View Abstract
Krishnan R, Cella D, Leonardi C, et al. Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol. 2007;157:1275-7
Date Published: December 2007
Keywords:
View Abstract
Torti DC, Feldman SR. Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol. 2007;57:1059-68
Date Published: December 2007
Keywords:
View Abstract
Weger W, Hofer A, Wolf P, et al. The angiotensin-converting enzyme insertion/deletion and the endothelin -134 3A/4A gene polymorphisms in patients with chronic plaque psoriasis. Exp Dermatol. 2007;16:993-8
Date Published: December 2007
Keywords:
View Abstract
Barker J. Skin diseases with high public health impact. Psoriasis. Eur J Dermatol. 2007;17:563-4
Date Published: November 2007
Keywords:
View Abstract
Bukhari IA. Multiple side effects of Efalizumab in a Saudi female with chronic persistent psoriasis followed by severe rebound after Efalizumab discontinuation. Saudi Med J. 2007;28:1745-7
Date Published: November 2007
Keywords:
View Abstract
C MartÃnez-Morán, C Sanz-Muñoz, A Mª Morales-Callaghan, et al. Pustular psoriasis induced by infliximab J Eur Acad Dermatol Venereol. 2007;21:1424-26
Date Published: November 2007
Keywords:
View Abstract
Ciocon DH, Kimball AB. Psoriasis and psoriatic arthritis: separate or one and the same? Br J Dermatol. 2007;157:850-60
Date Published: November 2007
Keywords:
View Abstract
Elder JT. IL-15 and psoriasis: another genetic link to Th17? J Invest Dermatol. 2007;127:2495-7
Date Published: November 2007
Keywords:
View Abstract
Kim YK, Pyo CW, Choi HB, et al. Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the Korean population. J Dermatol Sci. 2007;48:133-9
Date Published: November 2007
Keywords:
View Abstract
The rapid onset of multiple squamous cell carcinomas during etanercept treatment for psoriasis. Br J Dermatol. 2007;157:1067-8
Date Published: November 2007
Keywords:
View Abstract
Mody E, Husni ME, Schur P, et al. Multidisciplinary evaluation of patients with psoriasis presenting with musculoskeletal pain: a dermatology: rheumatology clinic experience. Br J Dermatol. 2007;157:1050-1
Date Published: November 2007
Keywords:
View Abstract
Nair B, Raval G, Mehta P. TNF-alpha inhibitor etanercept and hematologic malignancies: report of a case and review of the literature. Am J Hematol. 2007;82:1022-4
Date Published: November 2007
Keywords:
View Abstract
Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med. 2007;120:953-9
Date Published: November 2007
Keywords:
View Abstract
Tincani A, Andreoli L, Bazzani C, et al. Inflammatory molecules: a target for treatment of systemic autoimmune diseases. Autoimmun Rev. 2007;7:1-7
Date Published: November 2007
Keywords:
View Abstract
Tuxen AJ, Yong MK, Street AC, et al. Disseminated cryptococcal infection in a patient with severe psoriasis treated with efalizumab, methotrexate and ciclosporin. Br J Dermatol. 2007;157:1067-8
Date Published: November 2007
Keywords:
View Abstract
Valesini G, Iannuccelli C, Marocchi E, et al. Biological and clinical effects of anti-TNFalpha treatment. Autoimmun Rev. 2007;7:35-41
Date Published: November 2007
Keywords:
View Abstract
Zhang XJ, Yan KL, Wang ZM, et al. Polymorphisms in interleukin-15 gene on chromosome 4q31.2 are associated with psoriasis vulgaris in Chinese population. J Invest Dermatol. 2007;127:2544-51
Date Published: November 2007
Keywords:
View Abstract
Begon E, Michel L, Flageul B, et al. Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol. 2007;17:497-506
Date Published: October 2007
Keywords:
View Abstract
Campanati A, Goteri G, Simonetti O, et al. CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept. Br J Dermatol. 2007
Date Published: October 2007
Keywords:
View Abstract
Krishnan R, Cella D, Leonardi C, et al. Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol. 2007
Date Published: October 2007
Keywords:
View Abstract
Finzi A, Colombo D, Caputo A, et al.. Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. J Eur Acad Dermatol Venereol. 2007;21:1161-9
Date Published: October 2007
Keywords:
View Abstract
Hostetler SG, Zirwas M, Bechtel MA. Efalizumab-associated thrombocytopenia. J Am Acad Dermatol. 2007;57:707-10
Date Published: October 2007
Keywords:
View Abstract
Nijsten T, Meads DM, de Korte J, et al. Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients. J Invest Dermatol. 2007;127:2315-22
Date Published: October 2007
Keywords:
View Abstract
Oiso N, Ota T, Kawara S, et al. Pustular psoriasis and vitiligo in a patient with Turner syndrome. J Dermatol. 2007;34:727-29
Date Published: October 2007
Keywords:
View Abstract
Papp K, Berth-Jones J, Kragballe K, et al. Scalp psoriasis: a review of current topical treatment options. J Eur Acad Dermatol Venereol. 2007;21:1151-60
Date Published: October 2007
Keywords:
View Abstract
Reimus JL, Vingerhoets AJ, Soons PH, et al. Suffering in psoriasis patients: its relation with illness severity and subjective well-being. Int J Dermatol. 2007;46:1042-5
Date Published: October 2007
Keywords:
View Abstract
Sabat R, Philipp S, Höflich C, et al. Immunopathogenesis of psoriasis. Exp Dermatol. 2007;16:779-98
Date Published: October 2007
Keywords:
View Abstract
Sterry W, Strober BE, Menter A, et al. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol. 2007;157:649-55
Date Published: October 2007
Keywords:
View Abstract
Takahashi MD, Castro LG, Romiti R, et al. Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis. Br J Dermatol. 2007;157:828-31
Date Published: October 2007
Keywords:
View Abstract
van Beelen AJ, Teunissen MB, Kapsenberg ML, et al. Interleukin-17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol. 2007;7:374-81
Date Published: October 2007
Keywords:
View Abstract
van Beelen AJ, Teunissen MB, Kapsenberg ML et al. Interleukin-17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol.. 2007;7:374-81
Date Published: October 2007
Keywords:
View Abstract
Vestergaard C, Deleuran M, Kragballe K. Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab. J Eur Acad Dermatol Venereol. 2007;21:1272-4
Date Published: October 2007
Keywords:
View Abstract
Woo SM, Huh CH, Park KC, et al. Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib. J Dermatol. 2007;34:724-6
Date Published: October 2007
Keywords:
View Abstract
Belsõ N, Széll M, Pivarcsi A, et al. Differential Expression of D-Type Cyclins in HaCaT Keratinocytes and in Psoriasis. J Invest Dermatol. 2007
Date Published: September 2007
Keywords:
View Abstract
Lesueur F, Oudot T, Heath S, et al. ADAM33, a new candidate for psoriasis susceptibility. PLoS ONE. 2007;2:e906
Date Published: September 2007
Keywords:
View Abstract
Voulgari PV, Venetsanopoulou AI, Exarchou SA, et al. Sustained Clinical Response and High Infliximab Survival in Psoriatic Arthritis Patients: A 3-year Long-Term Study. Semin Arthritis Rheum. 2007
Date Published: September 2007
Keywords:
View Abstract
Citro V, Fristachi R, Tarantino G. Extensive psoriasis induced by pegylated interferon: a case report. J Med Case Reports. 2007;1:86
Date Published: September 2007
Keywords:
View Abstract
Pattison EJ, Harrison BJ, Griffiths CE, et al. Environmental risk factors for the development of psoriatic arthritis: results from a case control study. Ann Rheum Dis. 2007
Date Published: September 2007
Keywords:
View Abstract
R Saraceno, R Mannheimer, S Chimenti. Regional distribution of psoriasis in Italy J Eur Acad Dermatol Venereol. 2007
Date Published: September 2007
Keywords:
View Abstract
G Gokdemir, S Ari, A Köslü, et al. Adherence to treatment in patients with psoriasis vulgaris: Turkish experience
J Eur Acad Dermatol Venereol. 2007
Date Published: September 2007
Keywords:
View Abstract
Dayangac-Erden D, Karaduman A, Erdem-Yurter H. Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients. Arch Dermatol Res. 2007
Date Published: September 2007
Keywords:
View Abstract
de Groot M, Teunissen MB, Ortonne JP, et al. Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor. Arch Dermatol Res. 2007;299:305-13
Date Published: September 2007
Keywords:
View Abstract
Downs AM. Adalimumab vs. etanercept in psoriasis. Clin Exp Dermatol. 2007;32:593
Date Published: September 2007
Keywords:
View Abstract
Heinen-Kammerer T, Daniel D, Stratmann L, et al. Cost-effectiveness of psoriasis therapy with etanercept in Germany. J Dtsch Dermatol Ges. 2007;5:762-8
Date Published: September 2007
Keywords:
View Abstract
Reich K, Nestle FO, Wu Y, et al. Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis. Eur J Dermatol. 2007;17:381-6
Date Published: September 2007
Keywords:
View Abstract
Sampogna F, Tabolli S, Abeni D, et al. The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study. Br J Dermatol. 2007;157:508-13
Date Published: September 2007
Keywords:
View Abstract
Wachter T, Murach WM, Bröcker EB, et al. Recalcitrant lithium-induced psoriasis in a suicidal patient alleviated by tumour necrosis factor-alpha inhibition. Br J Dermatol. 2007;157:627-9
Date Published: September 2007
Keywords:
View Abstract
Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum. 2007;56:2886-95
Date Published: September 2007
Keywords:
View Abstract
Ho PY, Barton A, Worthington J, et al. Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis. 2007
Date Published: August 2007
Keywords:
View Abstract
Horn EJ, Fox KM, Patel V, et al. Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol. 2007
Date Published: August 2007
Keywords:
View Abstract
Reddy M, Davis C, Wong J, et al. Modulation of CLA, IL-12R, CD40L, and IL-2Ralpha expression and inhibition of IL-12- and IL-23-induced cytokine secretion by CNTO 1275. Cell Immunol. 2007;247:1-11
Date Published: August 2007
Keywords:
View Abstract
Stern RS. Psoralen and ultraviolet a light therapy for psoriasis. N Engl J Med. 2007;357:682-90
Date Published: August 2007
Keywords:
View Abstract
Bedini C, Nasorri F, Girolomoni G, et al. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function. Br J Dermatol. 2007;157:249-58
Date Published: August 2007
Keywords:
View Abstract
Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, et al. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 2007;57:1074-80
Date Published: August 2007
Keywords:
View Abstract
Helfrich YR, Kang S, Hamilton TA, et al. Topical becocalcidiol for the treatment of psoriasis vulgaris: a randomized, placebo-controlled, double-blind, multicentre study. Br J Dermatol. 2007;157:369-74
Date Published: August 2007
Keywords:
View Abstract
Watabe D, Kanno H, Yoshida A, et al. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1. Br J Dermatol. 2007;157:259-65
Date Published: August 2007
Keywords:
View Abstract
A Ammoury, F El Sayed, R Dhaybi, et al. Palmoplantar pustulosis should not be considered as a variant of psoriasis J Eur Acad Dermatol Venereol. 2007
Date Published: July 2007
Keywords:
View Abstract
C-CE Lan, C-S Wu, G-S Chen. Pretreatment tumour necrosis factor-a secretions from peripheral blood mononuclear cells of psoriatic patients do not correlate with rapid clinical response: urgent need for prognostic parameters J Eur Acad Dermatol Venereol. 2007
Date Published: July 2007
Keywords:
View Abstract
SC Carneiro, FF Cássia, F Lamy, et al. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages J Eur Acad Dermatol Venereol. 2007
Date Published: July 2007
Keywords:
View Abstract
Carrascosa JM, Soria X, Ferrándiz C. Effective management of a psoriatic flare with narrowband UVB phototherapy during efalizumab therapy without discontinuing treatment J Eur Acad Dermatol Venereol. 2007;21:828-829
Date Published: July 2007
Keywords:
View Abstract
Efalizumab Dermatol Ther. 2007;20:265-9
Date Published: July 2007
Keywords:
View Abstract
Fan X, Xiao F-L, Yang S, et al. Childhood psoriasis: a study of 277 patients from China J Eur Acad Dermatol Venereol. 2007;21:762-765
Date Published: July 2007
Keywords:
View Abstract
Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007;157:68-73
Date Published: July 2007
Keywords:
View Abstract
Gunast S, Marakli SS, Tuncer I, et al. Clinical and histopathological findings of ‘psoriatic neurodermatitis’ and of typical lichen simplex chronicus J Eur Acad Dermatol Venereol. 2007;21:811-817
Date Published: July 2007
Keywords:
View Abstract
Infliximab in the treatment of psoriasis in patients previously treated with etanercept. J Am Acad Dermatol. 2007;57:120-5
Date Published: July 2007
Keywords:
View Abstract
Jiaravuthisan MM, Sasseville D, Vender RB, et al. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol. 2007;57:1-27
Date Published: July 2007
Keywords:
View Abstract
Nedoszytko B, Szczerkowska-Dobosz A, Zablotna M, et al. Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population. Br J Dermatol. 2007;157:165-7
Date Published: July 2007
Keywords:
View Abstract
Gisondi P, Girolomoni G. Combination of efalizumab and acitretin in chronic plaque psoriasis J Eur Acad Dermatol Venereol. 2007
Date Published: June 2007
Keywords:
View Abstract
Ahmad K, Roger S. Development of Crohn disease in a patient on etanercept for psoriasis. Br J Dermatol. 2007
Date Published: June 2007
Keywords:
View Abstract
Akhyani M, Ehsani AH, Robati RM, et al. The lipid profile in psoriasis: a controlled study J Eur Acad Dermatol Venereol. 2007
Date Published: June 2007
Keywords:
View Abstract
Papoutsaki M, Chimenti MS, Costanzo A, et al. Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics. J Am Acad Dermatol. 2007
Date Published: June 2007
Keywords:
View Abstract
Chaidemenos GC, Mourellou O, Avgoustinaki N, et al. Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis
J Eur Acad Dermatol Venereol. 2007
Date Published: June 2007
Keywords:
View Abstract
Weatherhead S, Robson SC, Reynolds NJ. Management of psoriasis in pregnancy. BMJ. 2007;334:1218-20
Date Published: June 2007
Keywords:
View Abstract
Chamian F, Lin SL, Lee E, et al. Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis. J Transl Med. 2007;5:27
Date Published: June 2007
Keywords:
View Abstract
Costanzo A, Papoutsaki M, Mazzotta A, et al. Consecutive use of different biological therapies in the treatment of psoriasis. Br J Dermatol. 2007
Date Published: June 2007
Keywords:
View Abstract
Grjibovski AM, Olsen AO, Magnus P, et al. Psoriasis in Norwegian twins: contribution of genetic and environmental effects J Eur Acad Dermatol Venereol. 2007
Date Published: June 2007
Keywords:
View Abstract
Altobelli E, Petrocelli R, Marziliano C, et al. Family history of psoriasis and age at disease onset in Italian patients with psoriasis. Br J Dermatol. 2007;156:1400-1
Date Published: June 2007
Keywords:
View Abstract
Cañete JD, Santiago B, Cantaert T, et al. Ectopic lymphoid neogenesis in psoriatic arthritis. Ann Rheum Dis. 2007;66:720-6
Date Published: June 2007
Keywords:
View Abstract
Chang SE, Han SS, Jung HJ, et al. Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol. 2007;156:1272-7
Date Published: June 2007
Keywords:
View Abstract
Eghlileb AM, Davies EE, Finlay AY. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol. 2007;156:1245-50
Date Published: June 2007
Keywords:
View Abstract
Gudjonsson JE, Johnston A, Dyson M, et al. Mouse models of psoriasis. J Invest Dermatol. 2007;127:1292-308
Date Published: June 2007
Keywords:
View Abstract
Ho PY, Barton A, Worthington J, et al. HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis. Ann Rheum Dis. 2007;66:807-11
Date Published: June 2007
Keywords:
View Abstract
Lesueur F, Lefèvre C, Has C, et al. Confirmation of psoriasis susceptibility loci on chromosome 6p21 and 20p13 in French families. J Invest Dermatol. 2007;127:1403-9
Date Published: June 2007
Keywords:
View Abstract
Linardaki G, Katsarou O, Ioannidou P, et al. Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection. J Rheumatol. 2007;34:1353-5
Date Published: June 2007
Keywords:
View Abstract
Marzo-Ortega H, McGonagle D, Rhodes LA, et al. Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis. Ann Rheum Dis. 2007;66:778-81
Date Published: June 2007
Keywords:
View Abstract
Menter A, Hamilton TK, Toth DP, et al. Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study. Int J Dermatol. 2007;46:637-48
Date Published: June 2007
Keywords:
View Abstract
Rosenberg P, Urwitz H, Johannesson A, et al. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment. J Hepatol. 2007;46:1111-8
Date Published: June 2007
Keywords:
View Abstract
Tyring S, Gordon KB, Poulin Y, et al. Long-term Safety and Efficacy of 50 mg of Etanercept Twice Weekly in Patients With Psoriasis. Arch Dermatol. 2007;143(6):719-26
Date Published: June 2007
Keywords:
View Abstract
Weisenseel P, Kuznetsov AV, Ruzicka T, et al. Palmoplantar pustulosis is not inevitably associated with antigliadin antibodies. Br J Dermatol. 2007;156:1399-400
Date Published: June 2007
Keywords:
View Abstract
Yazici AC, Karabulut AA, Ozen O, et al. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study. J Dermatol. 2007;34:367-74
Date Published: June 2007
Keywords:
View Abstract
Magalhães RF, Velho PENF, Machado de Moraes A, et al. Linear psoriasis in Brazilian children and HLA haplotypes J Eur Acad Dermatol Venereol. 2007
Date Published: May 2007
Keywords:
View Abstract
Psoriasis. BMJ. 2007;334:953-4
Date Published: May 2007
Keywords:
View Abstract
Etanercept in infants: suberythrodermic, recalcitrant psoriasis in a 22 month-old child successfully treated with etanercept. Eur J Dermatol. 2007;17:245
Date Published: May 2007
Keywords:
View Abstract
de Boer OJ, van der Loos CM, Teeling P, et al. Immunohistochemical Analysis of Regulatory T Cell Markers FOXP3 and GITR on CD4+CD25+ T Cells in Normal Skin and Inflammatory Dermatoses. J Histochem Cytochem. 2007
Date Published: May 2007
Keywords:
View Abstract
Hagforsen E, Sunnerberg K, Michaelsson G, et al. Psoriasis Autoantigens in Normal Scalp Skin-Identification by Expression Cloning. J Invest Dermatol. 2007
Date Published: May 2007
Keywords:
View Abstract
Fulchiero GJ Jr, Salvaggio H, Drabick JJ. Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies. J Am Acad Dermatol. 2007;56:S65-S67
Date Published: May 2007
Keywords:
View Abstract
Gladman DD, Mease PJ, Healy P, et al. Outcome measures in psoriatic arthritis. J Rheumatol. 2007;34:1159-66
Date Published: May 2007
Keywords:
View Abstract
Gottlieb AB, Cooper KD, McCormick TS, et al. A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasis. Curr Med Res Opin. 2007;23:1081-92
Date Published: May 2007
Keywords:
View Abstract
Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol. 2007;119:1210-7
Date Published: May 2007
Keywords:
View Abstract
Antipsoriatic biologic agents for the treatment of atopic dermatitis. J Am Acad Dermatol. 2007;56:854-5
Date Published: May 2007
Keywords:
View Abstract
Korver GE, Callis K, Nelson T, et al. Cardiovascular risk in a well characterized cohort of the Utah psoriasis population. Presented at: Society for Investigative Dermatology 68th Annual Meeting. May 2007; Los Angeles, Calif. Presentation 379.
Date Published: May 2007
Keywords:
Ma F, Prodanovich S, Kirsner R. Vascular disease in patients with psoriasis. Presented at: Society for Investigative Dermatology 68th Annual Meeting. May 2007; Los Angeles, CA. Presentation 383
Date Published: May 2007
Keywords:
Weishaupt C, Metze D, Luger TA, et al. Treatment of pustular psoriasis with infliximab. J Dtsch Dermatol Ges. 2007;5:397-9
Date Published: May 2007
Keywords:
View Abstract
Zinnuroglu M, Dincel AS, Oztas MO, et al. Bone loss in patients with psoriatic arthritis and psoriasis vulgaris. Rheumatol Int. 2007
Date Published: April 2007
Keywords:
View Abstract
Eghlileb AM, Davies EE, Finlay AY, et al. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol. 2007
Date Published: April 2007
Keywords:
View Abstract
Komine M, Karakawa M, Takekoshi T, et al. Early Inflammatory Changes in the "Perilesional Skin" of Psoriatic Plaques: Is there Interaction between Dendritic Cells and Keratinocytes? J Invest Dermatol. 2007
Date Published: April 2007
Keywords:
View Abstract
Genovese MC, Mease PJ, Thomson GT, et al. Safety and Efficacy of Adalimumab in Treatment of Patients with Psoriatic Arthritis Who Had Failed Disease Modifying Antirheumatic Drug Therapy. J Rheumatol. 2007
Date Published: April 2007
Keywords:
View Abstract
Stamm TA, Nell V, Mathis M, et al. Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Rheum. 2007;57:487-94
Date Published: April 2007
Keywords:
View Abstract
Kremers HM, McEvoy MT, Dann FJ, et al. Heart disease in psoriasis. J Am Acad Dermatol.
Date Published: April 2007
Keywords:
View Abstract
Ahmad K, Rogers S. Two years of experience with etanercept in recalcitrant psoriasis. Br J Dermatol.
Date Published: April 2007
Keywords:
View Abstract
Antoniou C, Stefanaki I, Stratigos A, et al. The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital. Br J Dermatol. 2007;156:12-6
Date Published: April 2007
Keywords:
View Abstract
Baran W, Szepietowski JC, Mazur G, et al. TGF-beta(1) gene polymorphism in psoriasis vulgaris. Cytokine. 2007;38:8-11
Date Published: April 2007
Keywords:
View Abstract
Costanzo A, Peris K, Talamonti M, et al. Long-term treatment of plaque psoriasis with efalizumab: an Italian experience. Br J Dermatol. 2007;156:17-23
Date Published: April 2007
Keywords:
View Abstract
Ferrandiz C, Carrascosa JM. Managing moderate-to-severe psoriasis with efalizumab: experience at a single Spanish institute. Br J Dermatol. 2007;156:24-9
Date Published: April 2007
Keywords:
View Abstract
Guenther L, Lynde C, Ho V. Practical considerations for the initiation and maintenance of etanercept in the treatment of psoriasis. J Cutan Med Surg. 2007;11:S37-47
Date Published: April 2007
Keywords:
View Abstract
Kirklin D, Duncan J, McBride S, et al. A cluster design controlled trial of arts-based observational skills training in primary care. Med Educ. 2007;41:395-401
Date Published: April 2007
Keywords:
View Abstract
Kragballe K. Efalizumab in the treatment of chronic plaque psoriasis: experiences from the largest psoriasis treatment centre in Denmark. Br J Dermatol. 2007;156:7-11
Date Published: April 2007
Keywords:
View Abstract
Kuek A, Hazleman BL, Ostor AJ. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J. 2007;83:251-60
Date Published: April 2007
Keywords:
View Abstract
Leon A, Nguyen A, Letsinger J, et al. An attempt to formulate an evidence-based strategy in the management of moderate-to-severe psoriasis: a review of the efficacy and safety of biologics and prebiologic options. Expert Opin Pharmacother. 2007; 8: 617-32
Date Published: April 2007
Keywords:
View Abstract
Moore A, Gordon KB, Kang S, et al. A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis. J Am Acad Dermatol. 2007;56:598-603
Date Published: April 2007
Keywords:
View Abstract
Papp KA, Keystone EC, Shear NH. Mechanism of action, pharmacokinetics, and drug interactions of etanercept in dermatology. J Cutan Med Surg. 2007;11:S3-S13
Date Published: April 2007
Keywords:
View Abstract
Poulin Y, Gupta AK, Amiss JD. Efficacy of etanercept in the management of plaque psoriasis and psoriatic arthritis. J Cutan Med Surg. 2007;11:S14-22
Date Published: April 2007
Keywords:
View Abstract
Selenko-Gebauer N, Karlhofer F, Stingl G. Efalizumab in routine use: a clinical experience. Br J Dermatol. 2007;156:1-6
Date Published: April 2007
Keywords:
View Abstract
Theodossiadis PG, Markomichelakis NN, Sfikakis PP. TUMOR NECROSIS FACTOR ANTAGONISTS: Preliminary Evidence for an Emerging Approach in the Treatment of Ocular Inflammation. Retina. 2007;27:399-413
Date Published: April 2007
Keywords:
View Abstract
Zeichner JA, Lebwohl M. Potential complications associated with the use of biologic agents for psoriasis. Dermatol Clin. 2007;25:207-213
Date Published: April 2007
Keywords:
View Abstract
Katugampola RP, Lewis VJ, Finlay AY. The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis. Br J Dermatol.
Date Published: March 2007
Keywords:
View Abstract
Callen JP. Complications and adverse reactions in the use of newer biologic agents. Semin Cutan Med Surg. 2007; 26: 6-14
Date Published: March 2007
Keywords:
View Abstract
Goiriz R, Dauden E, Perez-Gala S, et al. Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers. Clin Exp Dermatol. 2007;32:176-9
Date Published: March 2007
Keywords:
View Abstract
Gomez M, Ruelas ME, Welsh O, et al. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient. J Drugs Dermatol. 2007;6:337-9
Date Published: March 2007
Keywords:
View Abstract
Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 2007;57:287-93
Date Published: March 2007
Keywords:
View Abstract
Kimball AB, Jackson JM, Sobell JM, et al. Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial. J Drugs Dermatol. 2007;6:299-306
Date Published: March 2007
Keywords:
View Abstract
Lee HH, Song IH, Friedrich M, et al. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.
Br J Dermatol. 2007; 156:486-91
Date Published: March 2007
Keywords:
View Abstract
Papp KA, Caro I, Leung HM, et al. Efalizumab for the treatment of psoriatic arthritis. J Cutan Med Surg. 2007;11:57-66
Date Published: March 2007
Keywords:
View Abstract
Price J, Bhosle M, Feldman SR, et al. Outcomes associated with the use of biologic agents in moderate to severe psoriasis. J Drugs Dermatol. 2007;6:259-67
Date Published: March 2007
Keywords:
View Abstract
Lowes MA, Chamian F, Abello MV, et al. Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series. BMC Dermatol. 2007;7:2
Date Published: February 2007
Keywords:
View Abstract
Chong BF, Wong HK. Immunobiologics in the treatment of psoriasis.
Clin Immunol.
Date Published: February 2007
Keywords:
View Abstract
Krueger GG, Langley RG, Leonardi C, et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med. 2007;356:580-92
Date Published: February 2007
Keywords:
View Abstract
Bovenschen HJ, Gerritsen WJ, van Rens DW, et al. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis. Arch Dermatol Res. 2007;298:457-63
Date Published: February 2007
Keywords:
View Abstract
Cohen JD, Bournerias I, Buffard V, et al. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. J Rheumatol. 2007;34:380-5
Date Published: February 2007
Keywords:
View Abstract
de Gannes GC, Ghoreishi M, Pope J, et al. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions.
Arch Dermatology. 2007; 143:223-31
Date Published: February 2007
Keywords:
View Abstract
Gladman DD, Mease PJ, Ritchlin CT, et al. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial. Arthritis and Rheum. 2007;56:476-88
Date Published: February 2007
Keywords:
View Abstract
Heymann WR. Tumor necrosis factor inhibitor-induced pustular psoriasis? J Am Acad Dermatol. 2007;56:327-9
Date Published: February 2007
Keywords:
View Abstract
Hutmacher MM, Nestorov I, Ludden T, et al. Modeling the exposure-response relationship of etanercept in the treatment of patients with chronic moderate to severe plaque psoriasis. J Clin Pharmacol. 2007;47:238-48
Date Published: February 2007
Keywords:
View Abstract
Kasche A, Pfab F, Hein R, et al. Severe psoriasis pustulosa palmaris et plantaris (Barber-Konigsbeck) treated successfully with soluble tumour necrosis factor receptor fusion protein (etanercept). J Eur Acad Dermatol Venereol. 2007;21:255-7
Date Published: February 2007
Keywords:
View Abstract
Menter A, Papp KA, Leonardi CL, et al. Short- and long-term efficacy and safety of adalimumab in a pivotal phase III study in adult patients with moderate to severe chronic plaque psoriasis. Presented at: American Academy of Dermatology 65th Annual Meeting. February 2007; Washington, DC.
Date Published: February 2007
Keywords:
Papp K, Leonardi C, Gordon K, et al. Efficacy and safety of adalimumab in a 120-week open-label extension study in patients with moderate to severe chronic plaque psoriasis. Presented at: American Academy of Dermatology 65th Annual Meeting. February 2007; Washington, DC.
Date Published: February 2007
Keywords:
Poulalhon N, Begon E, Lebbe C, et al. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity. Br J Dermatol. 2007;156:329-36
Date Published: February 2007
Keywords:
View Abstract
Roux CH, Brocq O, Leccia N, et al. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect? J Rheumatol. 2007;34:434-7
Date Published: February 2007
Keywords:
View Abstract
Safa G, Loppin M, Bousser AM, et al. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis. J Am Acad Dermatol. 2007;56:S19-20
Date Published: February 2007
Keywords:
View Abstract
Sri JC, Tsai CL, Deng A, et al. Osteomyelitis occurring during infliximab treatment of severe psoriasis. J Drugs Dermatol. 2007;6:207-10
Date Published: February 2007
Keywords:
View Abstract
Ubriani R, Van Voorhees AS. Onset of psoriasis during treatment with TNF-{alpha} antagonists: a report of 3 cases.
Arch Dermatology. 2007; 143: 270-2
Date Published: February 2007
Keywords:
View Abstract
Voulgari PV, Venetsanopoulou AI, Epagelis EK, et al. Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience. Ann Rheum Dis. 2007;66:270-1
Date Published: February 2007
Keywords:
View Abstract
van de Kerkhof PC, Mrowietz U, Segaert S, et al. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity? Br J Dermatol.
Date Published: January 2007
Keywords:
View Abstract
Elewski B, Leonardi C, Gottlieb AB, et al. Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis. Br J Dermatol. 2007;156:138-42
Date Published: January 2007
Keywords:
View Abstract
Menter A, Feldman SR, Weinstein GD, et al. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol. 2007;56:31.e1-15
Date Published: January 2007
Keywords:
View Abstract
Tekin NS, Tekin IO, Barut F, et al. Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients. Mediators Inflamm. 2007;2007:78454
Date Published: December 2006
Keywords:
View Abstract
Barcellos LF, Kamdar BB, Ramsay PP, et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol. 2006;5:924-31
Date Published: November 2006
Keywords:
View Abstract
Dixon WG, Watson KD, Lunt M, et al. Rates of myocardial infarction (MI) and cerebrovascular accident (CVA) in patients with rheumatoid arthritis (RA) treated with anti-TNF therapy: Results from the British Society of Rheumatology Biologics Register (BSRBR). Presented at: ACR/ARHP Annual Scientific Meeting. November 2006; Washington, DC. Presentation 681.
Date Published: November 2006
Keywords:
Kavanaugh A, Antoni C, Mease P, et al. Effect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritis. J Rheumatol. 2006;33:2254-9
Date Published: November 2006
Keywords:
View Abstract
Korver JE, Langewouters AM, Van De Kerkhof P, et al. Therapeutic effects of a 12-week course of alefacept on nail psoriasis. J Eur Acad Dermatol Venereol. 2006;20:1252-5
Date Published: November 2006
Keywords:
View Abstract
Sterry W, Stingl G, Langley RG, et al. Clinical Experience Acquired with Raptiva (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo-controlled trial. J Dtsch Dermatol Ges. 2006;4:947-56
Date Published: November 2006
Keywords:
View Abstract
Chan JR, Blumenschein W, Murphy E, et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med. 2006;203:2577-87
Date Published: October 2006
Keywords:
View Abstract
Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735-41
Date Published: October 2006
Keywords:
View Abstract
Gordon KB, Langley RG, Leonardi C, et al. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study. J Am Acad Dermatol. 2006;55:598-606
Date Published: October 2006
Keywords:
View Abstract
Nestorov I, Zitnik R, DeVries T, et al. Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis. Br J Clin Pharmacol. 2006;62:435-45
Date Published: October 2006
Keywords:
View Abstract
Papp KA, Toth D, Rosoph L. Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence. BMC Dermatol. 2006;4:947-56
Date Published: October 2006
Keywords:
View Abstract
Boehncke W-H, Brasie RA, Barker J, et al. Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus
J Eur Acad Dermatol Venereol. 2006;20:988-998
Date Published: September 2006
Keywords:
View Abstract
Kimhi O, Caspi D, Borstein N, et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Presented at: European League Against Rheumatism 2006 Congress. June 2006; Amsterdam, Netherlands. Presentation THU0322.
Date Published: June 2006
Keywords:
Kremer JM, Reed G, White B, et al. An analysis of risk factors and effect of treatment on the development of cardiovascular disease in patients with rheumatoid arthritis. Presented at: European League Against Rheumatism 2006 Congress. June 2006; Amsterdam, Netherlands. Presentation FRI0074.
Date Published: June 2006
Keywords:
View Synopsis
Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295:2275-85
Date Published: May 2006
Keywords:
View Abstract
Gottlieb AB, Hamilton T, Caro I, et al. Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial. J Am Acad Dermatol. 2006;54:S154-63
Date Published: April 2006
Keywords:
View Abstract
Mallbris L, Granath F, Hamsten A, et al. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006;54:614
Date Published: April 2006
Keywords:
View Abstract
Scheinfeld N. Efalizumab: a review of events reported during clinical trials and side effects. Expert Opin Drug Saf. 2006;5:197-209
Date Published: March 2006
Keywords:
View Abstract
Strober B, Gottlieb A, Leonardi C.. Levels of response of psoriasis patients with different baseline characteristics treated with etanercept. Presented at: 64th Annual Meeting of the American Academy of Dermatology. March 2006; San Francisco, Calif. Presentation P2890.
Date Published: March 2006
Keywords:
Ozgocmen S, Ozcakar L, Ardicoglu O, et al. Familial Mediterranean fever responds well to infliximab: single case experience. Clin Rheumatol. 2006;25:83-87.
Date Published: February 2006
Keywords: ankylosing spondylitis, antirheumatic agents, arthritis, Familial Mediterranean Fever (FMF), femoral, fever, infliximab, methotrexate, necrosis, pathogenesis, recurrence, remission, responses, spondylarthropathy, TNF-alpha, tumor necrosis factor (TNF)
View Abstract
Piskin G, Sylva-Steenland RM, Bos JD, et al. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol.. 2006;176:1908-15
Date Published: February 2006
Keywords:
View Abstract
Robinson D, Bala M, Wu Y, et al. Increased prevalence of cardiovascular risk factors among psoriasis patients: results from two large healthcare databases. Presented at: 64th Annual Meeting of the American Academy of Dermatology. February 2006; San Francisco, Calif. Presentation P2822.
Date Published: February 2006
Keywords:
View Synopsis
Esposito M, Saraceno R, Giunta A, et al. An Italian study on psoriasis and depression. Dermatology. 2006;212:123-7
Date Published: January 2006
Keywords:
View Abstract
Leonardi CL, Toth D, Cather JC, et al. A review of malignancies observed during efalizumab (Raptiva) clinical trials for plaque psoriasis. Dermatology. 2006;213:204-14
Date Published: January 2006
Keywords:
View Synopsis View Abstract
Shatin D, Rawson NS, Curtis JR, et al. Documented tuberculin skin testing among infliximab users following a multi-modal risk communication interventions. Pharmacoepidemiol Drug Saf. 2006;15:11-18
Date Published: January 2006
Keywords: adverse effects, arthritis, infliximab, psoriatic arthritis, rheumatoid arthritis, risk communication, tuberculin skin testing, tuberculosis
View Abstract
Chin G, Luxton G, Harvey JM. Infliximab and nephrotic syndrome. Nephrol Dial Transplant. 2005;20:2824-2826.
Date Published: December 2005
Keywords: ankylosing spondylitis, chimeric, infections, inflammatory bowel disease, infliximab, monoclonal antibodies, nephrotic syndrome, psoriasis, renal, rheumatoid arthritis, TNF-alpha, tumor necrosis factor (TNF)
View Abstract
Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141:1527-34
Date Published: December 2005
Keywords:
View Abstract
Kast RE. Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities—the role of bupropion. Leuk Res. 2005;29:1459-1463.
Date Published: December 2005
Keywords: apoptosis, arthritis, B lymphocytes, bupropion, Crohn's disease, etanercept, inflammation, lymphocytes, multiple myeloma, receptors, rheumatoid arthritis, safety, subcutaneous injections, synthesis, TNF-alfa, transmembrane, tumor necrosis factor (TNF)
View Abstract
Noguera-Pons R, Borras-Blasco J, Romero-Crespo I, et al. Optic neuritis with concurrent etanercept and isoniazid therapy. Ann Pharmacother. 2005;39:2131-2134.
Date Published: December 2005
Keywords: adverse effects, anti-inflammatory agents, arthritis, demyelinating disease, dosage, etanercept, intravenous, isoniazid, leflunomide, lesions, methotrexate, methylprednisolone, MRI, multiple sclerosis, NSAIDs, optic neuropathy, oral, prednisolone, rheumatoid arthritis, subcutaneous injections, tuberculosis
View Abstract
Warkentin TE, Kwon P. Immune thrombocytopenia associated with efalizumab therapy for psoriasis. Ann Intern Med. 2005;143:761-763.
Date Published: November 2005
Keywords: adrenal cortex hormones, adverse effects, dermatologic agents, efalizumab, immunology, monoclonal antibodies, psoriasis, thrombocytopenia
View Abstract
Behnam SM, Behnam SE, Koo JY. TNF-alpha inhibitors and congestive heart failure. Skinmed. 2005;4:363-368.
Date Published: November 2005
Keywords: clinical trials, congestive heart failure, dosage, etanercept, infliximab, mortality, psoriasis, TNF-alpha, tumor necrosis factor (TNF)
View Abstract
Gordon KB, Bonish BK, Patel T, et al. The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques. Br J Dermatol. 2005;153:945-953.
Date Published: November 2005
Keywords: adalimumab, biologic agents, biopsy, cell density, clinical trials, epidermal, humanized, immunopathogenesis, inflammation, keratinization, Langerhans, lesions, lichen planus, mechanism of action, monoclonal antibodies, psoriasis, seborrheic keratosis, skin, T cells, TNF-alpha, tumor necrosis factor (TNF)
View Abstract
Pershadsingh HA, Benson SC, Ellis CN. Improvement in psoriasis with rosiglitazone in a diabetic and a nondiabetic patient. Skinmed. 2005;4:386-90
Date Published: November 2005
Keywords:
View Synopsis View Abstract
Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-32
Date Published: November 2005
Keywords:
View Abstract
Mufti AH, Toye BW, McKendry RR, et al. Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use. Diagn Microbiol Infect Dis. 2005;53:233-238.
Date Published: November 2005
Keywords: arthritis, Crohn's disease, etanercept, infections, inflammatory, infliximab, mycobacterium infection, rheumatoid arthritis, TNF-alpha, tumor necrosis factor (TNF)
View Abstract
Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133-41
Date Published: November 2005
Keywords:
View Abstract
Scheinfeld N. Alefacept: a safety profile. Expert Opin Drug Saf. 2005;4:975-985.
Date Published: November 2005
Keywords: adverse effects, alefacept, antibodies, arthralgia, biologic agents, fatigue, headache, infections, malignancy, nausea, pruritus, serological study, T cells
View Abstract
Callejas-Rubio JL, Ortego-Centeno N, Lopez-Perez L, et al. Treatment of therapy-resistant sarcoidosis with adalimumab. Clin Rheumatol. 2005;1-2 [E-pub ahead of print].
Date Published: October 2005
Keywords: adalimumab, cytokines, etanercept, granuloma, immunoglobulin G, inflammation, infliximab, monoclonal antibodies, sarcoidosis, TNF-alpha, tumor necrosis factor (TNF)
View Abstract
Flor MJ, Cisneros JM. Acute respiratory failure in a patient treated with infliximab [in Spanish]. Enferm Infecc Microbiol Clin. 2005;23:503-504.
Date Published: October 2005
Keywords: infliximab, respiratory failure
View Abstract
Breedveld FC. Tumour necrosis factor antagonists: infliximab, adalimumab and etanercept [in Dutch]. Ned Tijdschr Geneeskd. 2005;149:2273-2277.
Date Published: October 2005
Keywords: adalimumab, ankylosing spondylitis, antirheumatic agents, arthritis, autoimmune disease, combination therapy, Crohn's disease, economics, etanercept, gastrointestinal agents, immunoglobulin G, inflammation, inflammatory, infliximab, mechanism of action, methotrexate, monoclonal antibodies, psoriasis, receptors, rheumatoid arthritis, TNF-alfa, tumor necrosis factor (TNF)
View Abstract
Anandacoomarasamy A, Kannangara S, Barnsley L. Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis. Intern Med J. 2005;35:638-640.
Date Published: October 2005
Keywords: arthritis, infliximab, rheumatoid arthritis, vasculitis
View Abstract
Askling J, Fored CM, Brandt L, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis. 2005;64:1421-6
Date Published: October 2005
Keywords:
View Abstract
Chi GC, Hsu FS, Yang CC, et al. Scleroderma and failed response to alefacept. Rheumatology (Oxford). 2005;44:1328-1330.
Date Published: October 2005
Keywords: alefacept, antirheumatic agents, recombinant fusion proteins, scleroderma
View Abstract
Dans M, Hivnor C, van Voorhees AS. Psoriatic onychopachydermoperiostitis: improvement with etanercept. Br J Dermatol. 2005;153:858-859.
Date Published: October 2005
Keywords: etanercept, onychopachydermoperiostitis
View Abstract
de Groot M, de Rie MA, Bos JD. Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris. Br J Dermatol. 2005;153:843-844.
Date Published
Print